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Abstract

Plants and phytochemicals have been used for centuries for therapeutic purposes.
Essential oils from these plants are complex mixtures and may possess a large
spectrum of biological activities many of them of clinical interest. Among the active
constituents of essential oils, monoterpenes, demonstrated valuable antioxidant,
antiviral, antimicrobial, anticancer, analgesic and anti-inflammatory effects. In recent
years, actions of monoterpenes on the function of ion channels have been
investigated. In the present study, effects of different monoterpenes including
carvacrol, carveol, d-carvone, eugenol, (+)-pulegone, thymol, thymoquinone,
menthome and limonene, on the function of the cloned α7 subunit of human
nicotinic acetylcholine (nACh) receptor expressed in Xenopus oocytes were
investigated by using the two-electrode voltage-clamp technique. All monoterpenes
caused a variable extent of reversible inhibition of ACh (100 μM)-induced currents
except vanillin and d-carvone. Carveol showed maximum potency of inhibition with
an IC50 value of 8.3 µM. The effect of carveol was further investigated and found to
be independent of the membrane potential. Carveol (10 µM) did not affect the
activity of endogenous Ca2+-dependent Cl- channels since the extent of inhibition by
carveol was unaltered by the intracellularly injected Ca2+ chelator BAPTA and
perfusion with Ca2+-free bathing solution containing 2 mM Ba2+. The effect of
carveol was associated with decreased potency of the ACh, and the inhibition was
fully reversed by increasing ACh concentrations, suggesting that this drug acts in a
competitive manner. In conclusion, these results demonstrate for the first time that
monoterpenes inhibit directly the function of human α7-nACh receptors expressed in
Xenopus oocytes. It appears that the extent of inhibition by monoterpenes differs
significantly depending on their chemical structures.
Keywords: Monoterpenes, human nicotinic α7 acetylcholine receptors, carveol,
Xenopus oocytes.
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)Title and Abstract (in Arabic

كارفيول و مركبات التربينات األحادية المتعلقة به تثبط وظيفة مستقبالت
األسيتايل كولين ألفا  7النيكوتينية
الملخص

لقرون طويلة ،استُخدمت النباتات و المواد المستخلصة منها في أغراض عالجية
متعددة .الزيوت العطرية عبارة عن خليط معقد من مواد كيميائية أظهرت عدة نشاطات حيوية
ذات أهمية عالجية .أثبتت الدراسات أن من هذه المواد ،التربينات األحادية لها تأثيرات عالجية
قيمة كمضادات لاللتهاب و األكسدة و األلم و مضادات ميكروبيبة و فيروسية و مضادات
للسرطان .ضمن هذا السياق ،التربينات األحادية ) (monoterpenesمن المواد التي جذبت
اهتمام الباحثين لدراسة تأثيرها على القنوات األيونية .في هذه الدراسة ،تم تقييم تأثير عدة
تربينات أحادية و هي كرفكرول و كارفيول و كرفون و إيوجينول و الثيمول و بوليجون و
فانيلين و منثون و ثيموكوينون و ليمونين على وظيفة مستقبالت األسيتايل كولين النيكوتينية
المكونة من وحدات ألفا  7و المستنسخة في بويضات ضفادع ( )Xenopusو ذلك باستخدام
تقنية تثبيت الجهد الكهربائي باستخدام قطبين كهربائيين .كل التربينات األحادية -عدا الفانيلين و
الكارفون -قللت بدرجات مختلفة حجم التيار الناتج عن  011ميكرو مول من األسيتايل كولين و
ذلك بصورة قابلة لالنعكاس .و قد ظهر أن كارفيول هوالمثبط االكثر فعالية حيث أن تركيز 3.8
ميكرو مول ثبط  %01من حجم التيار األصلي .بعد إجراء تجارب إضافية تبين أن تأثير
الكارفيول اليعتمد على جهد الغشاء الخلوي .كما أن الكارفيول لم يأثر على نشاط و عمل قنوات
الكلوريد المعتمدة على الكالسيوم المتواجدة في غشاء البيوضات حيث أن درجة التثبيط التي
أحدثها الكارفيول لم تتغير في البويضات التي حقنت بمادة  BAPTAالحابسة للكالسيوم و
نضحت بمحلول خالي من الكالسيوم .تأثير الكارفيول قلل من فعالية األسيتايل كولين و هذا
التأثير انعكس تماما عند زيادة تركيز األسيتايل كولين مما دل على أن التثبيط الناتج عن
الكارفيول ذو طبيعة تنافسية .و كنتيجة للدراسة ،فقد تبين أن العديد من التربينات األحادية تثبط
عمل مستقبالت األسيتايل كولين النيكونينية المكونة من وحدات ألفا  7المستنسخة في بويضات
ضفدع ( ) Xenopusبشكل مباشر .درجة التثبيط الناتجة عن التربينات األحادية تعتمد بدرجة
كبيرة على تركيبها الكيميائي.
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Chapter 1: Introduction
1.1. Introduction to Monoterpenes
Plants and phytochemicals have been used for centuries for therapeutic
purposes and constitute the backbone of pharmacology and medicine. In recent
years, there has been an increased interest in unveiling the biological activities of
specific phytochemicals and understanding the mechanisms of action of their
molecular and cellular effects. One of the major, biologically active groups of
phytochemicals are the terpenes. Terpenes are a large and diverse group of naturally
occurring compounds that exist as the main constituents of essential oils of several
plant families such as Apiaceae, Asteraceae, Lamiaceae (Labiatae), Pinaceae,
Piperaceae, Rutaceae,

and Zingiberaceae

(Ramawat et al, 2013; Silvestre &

Gandini, 2008).
Terpenes are mostly hydrocarbon in nature and their building block is a fivecarbon isoprene unit (2-methyl-1, 3-butadiene) (Figure 1.1). Isoprene was discovered
by Wallach in 1887, who defined the structure of most terpenes as the ‘head-to-tail’
condensation of isoprene units (Figure 1.1) which is known as ‘isoprene rule’
(Christmann, 2010). Therefore, terpenes can be classified according to the number of
isoprene units with a molecular formula of (C5H8)n (n is the number of isoprene
units). Accordingly, there are monoterpenes, sesquiterpenes, diterpenes, triterpenes
and tetraterpenes with two, three, four, six, and eight isoprene units respectively
(Aldred et al, 2009).
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Figure 1.1: Chemical structure of the Terpenes. Isoprene constitute the main building block
of terpenes and can be found in either “head to tail” or “tail to tail” configurations (Blaber, 2001).

1.2 Physicochemical properties of Monoterpenes
Most monoterpenes are highly volatile and non-polar (lipophilic) in nature
which enables them partition and dissolve in cellular membranes. They are colorless
liquids that are chemically reactive and have characteristic aromatic odors (Clarke,
2008).

Monoterpenes

possess

variable basic skeletons

and

also

exhibit

stereoisomerism (Ramawat et al, 2013). Monoterpenes can exist in acyclic structures
such as myrcene, as well as cyclic structures that could be monocyclic as (+)limonene and dicyclic as (-)-α pinene (see Figure 1.2). Moreover, there are a wide
range of oxygenated derivatives (alcohols, aldehydes, ketones and carboxylic acids)
that can be derived from native basic skeletons (Silvestre & Gandini, 2008). These
oxygenated forms are known as terpenoids (Clarke, 2008)
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Figure 1.2: Structure of some cyclic and acyclic monoterpenes (Heyen & Harder, 2000)

Figure 1.3: Structure of oxygenated terpenes (terpenoids)
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1.3 Biological activity of Monoterpenes
Essential oils have been used for therapeutic and culinary purposes for
centuries. Several ancient civilizations valued the therapeutic and medicinal effects
of essential oils and utilized those natural oils for health promotion, well-being and
mental relaxation. Essential oils are complex mixtures and may possess a large
spectrum of biological activity many of them of clinical interest. Many recent
investigations focused on studying the biological effects of essential oils as a whole
or, more recently, on their major isolated active constituents i.e. monoterpenes.
These studies have found that monoterpenes have valuable anti-oxidant, anti-viral,
anti-microbial, anti-cancer, analgesic and anti-inflammatory effects (for reviews, see
Acharya et al, 2010; Clifford & DiGiovanni, 2010; de Cassia da Silveira e Sa et al,
2013; Guimaraes et al, 2013; Kamatou et al, 2013; Nostro & Papalia, 2012;
Slamenova & Horvathova, 2013; Wagner & Elmadfa, 2003). Some of these studies
have been reviewed in the following sections.
1.3.1. Anti-oxidant activity
Excessive formation of reactive oxygen species (ROS), as a result of
exposure to environmental factors like pollutants and UV radiation, constitutes a
major initiation factor in the progression of many pathological conditions. When the
formation of ROS reaches beyond the capacity of cellular antioxidant defenses, it
leads to lipid peroxidation and eventually damages lipid membranes, DNA bases and
proteins (Frankel & Neff, 1983). Several studies demonstrated the potential
antioxidant properties of single or multiple monoterpenes (for reviews, see Koziol et
al, 2014; Porres-Martinez et al, 2014; Raskovic et al, 2014; Slamenova &
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Horvathova, 2013). In a study on the antioxidant effects of eucalyptus and clove oils,
thymol and eugenol (400 µg/ml), it has been shown that pure isolated monoterpenoid
that exists as a major constituent of these oils caused inhibition of the formation of
malonaldehye (product of lipid oxidation) by 43.3% and 57.2%, respectively (Lee &
Shibamoto, 2001). In a later study, the antioxidant potential of carvone, α-terpineol
and perillyl alcohol was investigated. Carvone showed maximum activity (IC50 32.1
g/L) that was 10 and 23 times greater than the activity of α-terpineol (IC50 332.8
g/mL) and perillylacohol (IC50 738.3 g/mL) (Bicas et al, 2011). Recent investigation
of the antioxidant properties of isolated monoterpenes in Spanish sage, α-pinene and
1,8-cineole, demonstrated considerable protection of cells against H2O2-induced
oxidative stress. ROS production was significantly inhibited by 1,8 cineole (30-45%
decrease at concentrations of 10 and 25 µM) (Porres-Martinez et al, 2014). Further
evaluation of the antioxidant activity of the individual isolated monoterpenes is
needed for better understanding of their actions.
1.3.2. Anti-inflammatory activity
Inflammation is associated with a cascade of biochemical events including
the formation of cytokines and inflammatory mediators that leads to inflammatory
damage of tissues (for review Kemp et al, 2008; Kovacs et al, 1994; Rosengren &
Delves, 1998). In the context of finding new natural anti-inflammatory agents,
essential oils and monoterpenes have been studied in several in vitro and in vivo
models.
In an earlier study, 1,8-Cineole (cineole) demonstrated anti-inflammatory
activity when used orally in doses ranging from 100 to 400 mg/kg in different
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inflammation models in rats (Santos & Rao, 2000). Another study by the same
group, a monoterpene oxide, 1, 8-cineole that exists in several essential oils was
evaluated for its anti-inflammatory activity using the trinitrobenzenesulfonic acid
(TNBS)-induced colitis model in rats (Santos et al, 2004). In this study, both 200 and
400 mg/kg doses of 1, 8-cineole caused a significant decrease in gross colonic
damage scores and wet weights of colonic segments of treated rats when compared
with vehicle treated rats. This effect was evident only in rats that were pre-treated
with this compound but not the post-treated rats. 1, 8-cineole also reduced
myeloperoxidase activity and increased glutathione levels (Santos et al, 2004),
suggesting the potential value of this compound in preventing gastrointestinal
inflammation and ulceration.
Several studies reported an anti-inflammatory effect of carvacrol, an aromatic
cyclic monoterpene that exists as a major constituent in the volatile oil of thyme
(Nabavi et al, 2015).

In a recent study,(Hotta et al, 2010) it was found that

carvacrol suppresses the activity of cycloxygenase-2 (COX-2), the rate-limiting
enzyme in prostaglandin and other inflammatory mediator synthesis, through a
mechanism involving peroxisome proliferator-activated receptors α and γ (PPARs).
They showed that carvacrol can activate PPAR α and γ which in turn causes
concentration dependent suppression of COX-2 expression (40% and 60%
suppression by 200 and 400 µM carvacrol incubated for 24 hours) when examined in
cell-based transfection assays using bovine arterial endothelial cells. In this study
(Hotta et al, 2010), it was also shown that carvacrol caused suppression of
lipopolysacharide-induced COX-2 mRNA and protein expression in macrophage-
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like U937 cells. Collectively, these results indicate that monoterpenes have
significant anti-inflammatory activities that might be of clinical value.
1.3.3. Analgesic activity
Pain has

been

reported

for seeking medical attention

(Ruoff,

to

be

the

2002). Different

most
classes

common reason
of

analgesic

medication play a central role in the management of painful conditions. However, in
many chronic pain conditions such as cancer and neuropathic pain, currently
available pain killers are clearly insufficient for proper control of pain (Okuse,
2007). As a result, the search for novel analgesic agents has been a major focus for
discovery and development of new drugs. In this context, many monoterpenes have
proven to be effective pain relieving molecules in various experimental pain models
(reviewed de Sousa, 2011; Guimaraes et al, 2013; Guimaraes et al, 2014). Carvacrol
is one of the monoterpenes that demonstrated clear antinociceptive effect using
different pain models (Cavalcante Melo et al, 2012; de Santana et al, 2014).
Carvacrol showed activating effects on PPAR α and γ which are known to regulate
the expression of COX-2 enzyme responsible for synthesis of multiple pain and
inflammatory mediators. In this study, carvacrol inhibited LPS-induced COX-2
mRNA and protein expression in human macrophage-like U937 cells (Hotta et al,
2010). Furthermore, carvacrol demonstrated anti-hypernociceptive and antiinflammatory properties when examined in mice using mechanical hypernociception
models. Systemic pretreatment with carvacrol (50 or 100 mg/kg; i.p.) inhibited the
development of edema and mechanical hypernociception caused by carrageenan and
TNF-α. Besides this, carvacrol significantly decreased tumor necrosis factor α (TNFα) levels in pleural lavage and suppressed the recruitment of leukocytes without
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affecting their morphology (Guimaraes et al, 2012b a). This monoterpene also
caused a significant antinociceptive effect on formalin-, capsaicin-, and glutamateinduced orofacial nociception in mice (Guimaraes et al, 2012a). Carvone is a
monoterpene ketone that was proved to have antinociceptive activity associated with
decreased peripheral nerve excitability when investigated using writhing and
formalin tests in mice (Goncalves et al, 2008). Linalool is one of the monoterpenes
that was clearly reported to demonstrate antinociceptive properties using variable
experimental models. Multiple reports showed that this compound reduced pain
sensation through modulation of muscarinic, opioid, dopaminerigic, adenosinergic
and glutamatergic systems (Batista et al, 2011; Batista et al, 2010; Batista et al,
2008; Peana et al, 2003; Peana et al, 2004a; Peana et al, 2004b; Peana et al, 2006a;
Peana et al, 2006b). Other studies suggested the involvement of nicotinic receptors at
the neuromuscular junction (Re et al, 2000). Many other monoterpenes have also
shown significant analgesic activities, in several in vitro and in vivo pain models (de
Sousa, 2011), suggesting that monotepenes might be good candidates for analgesic
drug development.
1.3.4. Antimicrobial activity
It is well established that some essential oils have antimicrobial properties
likely due to their function in most plants as a defensive mechanism (Mahmoud &
Croteau, 2002). Recently, there has been an increased interest in essential oils and
their constituents as preservatives to prevent food-borne diseases (reviewed Burt,
2004). The aromatic monoterpene carvacrol and various essential oils containing
carvacrol have been studied. Carvacrol demonstrated a wide spectrum of activity
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against many Gram-positive and Gram-negative bacteria, molds and yeasts (Nostro
& Papalia, 2012). In a recent study by Rivero-Cruz et al. (2011), the antimicrobial
properties of the essential oil of Poliomintha longiflora and Lippia graveolens and
their major constituents were examined. Carvacrol showed better antimicrobial
activity than other components such as thymol and p-cymene. Carvacrol had a
minimal inhibitory concentration (MIC) of 128 µg/ml compared to 256 to 1024
µg/ml MIC values of thymol and p-cymene against various bacterial strains (RiveroCruz et al, 2011). Another study investigated the effects of essential oils and its
constituents for prevention of oral infections (Botelho et al, 2007). Using the disk
diffusion method, they showed that essential oil of Lippiasidoides and its major
constituents, thymol and carvacrol, had significant antibacterial and anti-candidal
properties. Thymol and carvacrol showed better inhibitory effect compared to the
essential oil in specific bacterial strains and Candida albicans. MIC values for the
constituents ranged from 2.5 to 5.0 mg/ml while MIC for the oil ranged from 5 to 10
mg/ml (Botelho et al, 2007). Minimum fungicidal concentration of carvacrol was 2.5
mg/ml while thymol showed similar activity to the essential oil.

Minimum

bactericidal concentration of the essential oil was 20-40 mg/ml while it was 5.0
mg/ml and 10 mg/ml for carvacrol and thymol respectively (Botelho et al, 2007).
Collectively, these studies emphasize the potential for utilizing essential oils and
monoterpenes as antimicrobial agents or adjuvant to conventional treatment.
1.3.5. Anti-carcinogenic activity
Cancer is a chronic process characterized by abnormal cell proliferation and
differentiation. Chemoprevention is a pharmacological approach to arrest or reverse
the process of carcinogenesis mainly by inhibiting enzymes or receptors of chemical
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mediators that play an important role especially during the initiation and progression
phases. Chemotherapy mainly involves inhibition of tumor cell proliferation and
enhancing apoptosis (Sporn & Suh, 2000). There are many studies reporting that
some monoterpenes show either chemopreventive or chemotherapeutic effects. For
example, in a study investigating anticancer activity of thymol using peripheral
blood mononuclear cells (PBMC) and promyelotic cancer cell line HL-60, it was
shown that thymol has dose dependent cytotoxic effects on HL-60 cells after 24h of
exposure starting from 25µM. However, thymol did not show any cytotoxic effect in
normal human PBMC up to 48 hours of exposure (Deb et al, 2011). In a similar
study exploring the apoptotic potential of d-limonene in two human leukemia cell
lines (K562 and HL60 cell lines), it was shown that d-Limonene induced apoptosis
in a dose-dependent manner starting from 0.1mM up to 0.8 mM with similar potency
in both cell lines (Ji et al, 2006).

The anticarcinogenic actions of various

monoterpenes have been further discussed in recent reviews (Bhalla et al, 2013;
Gautam et al, 2014; Sobral et al, 2014).
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1.4. Effects on Monoterpenes on Different Ion Channels and Receptors
Ion channels are integral membrane proteins that control passage of charged
ions (Na+, K+, Ca2+, or Cl−) through the cell’s lipid bilayer. Opening and closing
(gating) of these channels can be controlled by membrane voltage, ligand binding,
stretch, or other physical stimuli. Any of these events deforms the channel protein
affecting its conformation leading to opening of the gate and ion permeation (for
reviews see Cannon et al, 2014; Tien et al, 2014; Weir, 2013; Wu & Cui, 2014).
Activity of ion channels underlies the fundamental basis of cellular excitability,
muscle contraction, neurotransmitor release, excitation transcription coupling,
hormone secretion, and other transmembrane signaling processes (Cannon et al,
2014; Tien et al, 2014). Many drugs exert their therapeutic effects by acting on the
ion channels of various excitable and non-excitable cells. Many phytochemicals have
provided opportunities for development of new medications. In this context the
effects of monoterpenes have been recently investigated on the functional properties
of various ion channels (de Araújo et al, 2011). The results of some of the recent
studies will be reviewed in the following sections.
1.4.1. Sodium channels
Voltage-gated sodium channels are important for initiation of action
potentials in neurons, muscle, and other excitable cells. Sodium (Na+) channels are
activated when membrane depolarization induces conformational changes in the
channel structure leading to opening of the pore allowing sodium influx. Local
anesthetic, antiepileptic, and antiarrhythmic drugs bind to a receptor site within the
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pore of the Na+ channel and block it, whereas many classes of neurotoxins bind to
distinct receptor sites and alter sodium channel function (Catterall et al, 2013).
In an earlier study (Haeseler et al, 2002), the effects of thymol and menthol
were evaluated on whole cell sodium inward currents via heterologously (HEK293
cells) expressed rat neuronal and human skeletal muscle sodium channels. Sodium
currents were inhibited with half maximal concentration (IC50) values of 104 and 149
µM for thymol and 376 and 571 µM for menthol for the skeletal muscle and the
neuronal Na+ channel, respectively. The blocking potency of both compounds
increased at depolarized holding potentials (Haeseler et al, 2002). The results of this
study suggested that the antinociceptive and local anesthetic effects of thymol and
menthol may be mediated via blockade of Na+ channels. In agreement with these
results, Gaudioso et al., (2012) examined the effect of menthol on voltage-gated Na+
channels in dorsal root ganglion (DRG) neurons. By use of a patch clamp, the effects
of menthol application were evaluated on tetrodotoxin (TTX)-resistant Nav1.8 and
Nav1.9 channel subtypes in DRG neurons, and on TTX-sensitive Na+ channels in
immortalized DRG neuron-derived F11 cells. The results indicated that menthol
inhibited voltage-gated Na+ channels in a concentration, voltage, and frequencydependent manner. Menthol promoted fast and slow inactivation states, causing usedependent depression of Na+ channel activity (Gaudioso et al, 2012). In current
clamp recordings, menthol inhibited firing at high-frequency stimulation with
minimal effects on normal neuronal activity. Furthermore it was found that low
concentrations of menthol cause analgesia in mice, relieving pain produced by a Na+
channel-targeting toxin. In this study, it was concluded that menthol is a state
selective blocker of Nav1.8, Nav1.9, and TTX-sensitive Na+ channels, indicating a
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role for Na+ channel blockade in the efficacy of menthol as a topical analgesic
compound (Gaudioso et al, 2012).
Recently, two groups, investigated the effect of carvacrol and related
monoterpenes on Na+ channels of mammalian (Goncalves et al, 2010) and vertebrate
(Kawasaki et al, 2013; Matsushita et al, 2013) neurons. Goncalves et al., (2010)
investigated the effects of (+) and (-)-carvone, carvacrol, carveol, and limonene on
compound action potential (CAP) characteristics using a modified single sucrose-gap
method. It was demonstrated that (-)-carvone was less potent (IC50=10.7 mM) in
reducing nerve excitability than its enantiomer, (+)-carvone (IC50=8.7 mM). In a
structure-activity relationship study, it was demonstrated that hydroxyl groups in the
carveol and carvacrol molecules enhanced the CAP blocking-effect, while the
absence of the oxygen moiety in limonene resulted in the effect being almost
abolished. In another study (Kawasaki et al, 2013), it was shown that (-)-menthol
and (+)-menthol concentration-dependently reduced CAP peak amplitude with IC50
values of 1.1 and 0.93 mM, respectively. However, other monoterpenes such as pmenthane, limonene and menthyl chloride at 7-10 mM minimally affected CAPs. On
the other hand, (-)-menthone, (+)-menthone, (-)-carvone, (+)-carvone and (-)-carveol
and pulegone inhibited CAPs with potencies similar to that of menthol (Kawasaki et
al, 2013). In another study by Joca and his co-researchers (Joca et al, 2012),
carvacrol’s effect was tested on CAP in isolated rat sciatic nerve. In agreement with
previous reports, carvacrol reversibly blocked the excitability of the rat sciatic nerve
in a concentration-dependent manner with an IC50 value of 0.5 mM. Also, carvacrol
blocked the generation of action potentials (IC50= 0.36 mM) of the intact DRG
neurons without altering the resting potential and input resistance (Joca et al, 2012).
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Furthermore, carvacrol reduced the voltage-gated Na+ current of dissociated DRG
neurons (IC50= 0.37 mM). In conclusion these studies demonstrated that carvacrol
blocks neuronal excitability by direct inhibition of the voltage-gated Na+ current
suggesting that this compound can act as a local anesthetic.
Eugenol, a monoterpenoid widely used in dentistry for its anesthetic
properties, was investigated for its effect on voltage-gated Na+ channels (Cho et al,
2008; Park et al, 2006). Cho et al demonstrated that an inhibitory effect of eugenol
was evident for both TTX-sensitive and TTX-resistant Na+ channels in rat DRG
neurons. The KD values were 308 µM and 543 µM for TTX-sensitive and insensitive
Na+ channels, respectively. Eugenol did not influence the activation voltage of either
type of sodium current. However, eugenol moved the steady-state inactivation curves
of both Na+ currents to a hyperpolarizing direction and reduced the maximal Na+
current (Cho et al, 2008) suggesting that eugenol inhibits sodium currents by
interacting with resting and inactivated channels. The recovery from inactivation of
both Na+ currents was slowed by eugenol. But, the eugenol inhibition of Na+ currents
was not dependent on the stimulus frequency. In another study, using a whole-cell
patch-clamp technique, the effect of eugenol was tested on voltage-gated sodium
channels in rat dental primary afferent neurons (Park et al, 2006). Eugenol inhibited
action potentials and two types of Na+ currents; TTX-resistant and TTX-sensitive.
Another group (Moreira-Lobo et al, 2010) examined the effect of eugenol on action
potentials recorded intracellularly from rat superior cervical ganglion (SCG). They
showed that eugenol caused reversible, concentration-dependent blockage of action
potentials with an IC50 of 0.31 mM (Moreira-Lobo et al, 2010). The results of these
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studies suggested that inhibition of Na+ current can be considered as one of the
mechanisms by which eugenol exerts analgesia.
In DRG neuron, another monoterpene, linalool reduced the amplitude of
action potentials in a reversible and concentration dependent manner with an IC50 of
1.85 mM (Leal-Cardoso et al, 2010). Linalool also inhibited excitability of the
sciatic nerve with an IC50 of 0.78 mM (Leal-Cardoso et al, 2010). In this study, it
was also shown that linalool, in the concentration range of 0.1 to 6 mM, reversibly
blocked the generation of action potentials in intact DRG neurons and inhibited the
sodium current of dissociated DRG neurons (Leal-Cardoso et al, 2010). In another
study using newt olfactory receptor cells, linalool inhibited voltage-dependent Na+
currents with an IC50 of 0.56 mM (Narusuye et al, 2005).
1.4.2 Calcium channels
Voltage-gated Ca2+ channels are responsible for controlling Ca2+ influx
through the plasma membrane. Entrance of extracellular Ca2+ through these channels
is crucial for many physiological functions of excitable cells such as neurons and
various types of muscle. The structural diversity of Ca2+ channels is related to their
function in different tissues, such as neurotransmitter release from nerve endings,
cardiac and smooth muscle contraction, Ca2+-dependent modulation of enzyme
activity and gene transcription (Reuter et al, 2013).
In early studies, several monoterpenes have been shown to modulate the
functions of voltage-dependent Ca2+ channels. Among these monoterpenes, menthol
has attracted much interest. High-potassium induced Ca2+ increases in Leech neurons
(Dierkes et al, 1997), synaptosomes and chick retinal neurons (Hawthorn et al, 1988)
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have been shown to be suppressed by menthol. Menthol inhibits K+ depolarizationinduced and electrically stimulated responses in ileum, and atrial and papillary
muscles. IC50 values in the ileac preparation ranged from 7.7 to 28.1 µg/ml and in
the cardiac preparations from 10.1 to 68.5 µg/ml. Furthermore, both menthol and
peppermint oil competitively inhibited specific binding of [3H]nitrendipine and
[3H]PN 200-110 to smooth and cardiac muscle and neuronal preparations with
potencies comparable to those measured in pharmacological experiments (Hawthorn
et al, 1988). In another study (Sidell et al, 1990), brief exposure of LA-N-5 cells to
menthol

decreased

the

depolarization-induced

Ca2+

influx

though

both

dihydropyridine (DHP)-sensitive and DHP-insensitive channels. The effect was
concentration dependent with IC50 value of 0.25 mM, rapid in onset and readily
reversible. In a recent study, in agreement with earlier results, menthol has been
shown to induce relaxation and inhibit contraction in rat aorta, mesenteric and
coronary arteries, primarily through inhibiting Ca2+ influx via nifedipine-sensitive
Ca2+ channels (Cheang et al, 2013). Similarly, the results of another study indicated
that menthol (0.1-30 mM) induced spasmolytic effects in human colon circular
muscle inhibiting contractility of the gastrointestinal smooth muscle, by blocking
Ca2+ influx through L-type Ca2+ channels (Amato et al, 2014). Similar results have
also been reported in bronchial smooth muscle (Wright et al, 1997) where menthol
caused relaxation of KCl and ACh preconstricted bronchi in vitro.
In addition to functional studies, there have also been electrophysiological
investigations. The effects of menthol (0.1-0.5 mM) on Ca2+ current inactivation was
studied in Helix neurons (Swandulla et al, 1986). External, but not internal,
application of menthol accelerated the Ca2+-dependent rapid phase of inactivation.
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Later, the effect of menthol on voltage-dependent Ca2+ currents was investigated in
cultured dorsal root ganglion cells from chick and rat embryos (Swandulla et al,
1987). Application of menthol (0.1-1 mM) had different effects on the various types
of Ca2+ currents in these neurons. Below -20 mV, the low threshold Ca2+ currents
were reduced in amplitude in a dose-dependent manner by menthol with little effect
on their activation kinetics. In contrast, the time course of inactivation of the highthreshold Ca2+ currents, activated above - 20 mV from a holding potential of - 80
mV, was drastically accelerated by external menthol. The action of menthol was
unchanged with more positive holding potentials (-50 mV). Importantly, menthol
exerted its action only when applied from the outside. Collectively, the results of
these studies indicated that menthol blocks Ca2+ currents through the low voltageactivated Ca2+ channel, and facilitates inactivation gating of the classical high
voltage activated Ca2+ channel. Recently, Baylie and his group investigated the
actions of menthol on L-type Ca2+ currents in rabbit ventricular myocytes at nearphysiological temperature (~35°C) using whole-cell recording (Baylie et al, 2010).
Menthol, concentration-dependently, inhibited peak Ca2+ currents (IC50=74.6). In
addition, menthol blocked the late currents remaining at the end of depolarising
pulses with greater efficacy (96.1% block at 1 mM) than peak Ca2+ currents (68.9 %
block at 1 mM) (Baylie et al, 2010).
In cardiac muscle, other monoterpenes have been shown to modulate the
function of L-type Ca2+ channels. The negative inotropic effect of Pulegone was
investigated in guinea pig atria (de Cerqueira et al, 2011).The effects of pulegone
were compared with nifedipine, a well-known L-type Ca2+ channel blocker, and
pulegone showed a similar pattern of concentration-dependent inhibition of atrial
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contractility to that of nifedipine with much lower potency. Concentration-response
curves demonstrated an IC50 of pulegone of 777µM compared to 1.1 µM for
nifedipine. To explore the involvement of L-type Ca2+ channel in the negative
inotropic effects of pulegone, they used the selective L-type Ca2+ channel agonist,
BAY K8644. In these experiments, upon preincubation with 3.2 mM pulegone, the
EC50 of BAY K8644 increased significantly from 0.1 μM to 0.6 μM. To further
confirm the role of L-type Ca2+ channels, whole-cell patch clamp experiments were
preferred in isolated mouse ventricular myocytes exposed to pulegone (de Cerqueira
et al, 2011).Pulegone caused a reversible inhibitory effect on peak L-type Ca2+
current. In another set of experiments, using isolated cardiomyocytes pre-loaded with
the intracellular Ca2+ indicator Fluo4-AM, the effect of pulegone was examined on
global Ca2+ transients.The cells were electrically stimulated to record intracellular
Ca2+ transients. The results, consistent with the previous findings, indicated that
pulegone, concentration-dependently, reduced intracellular Ca2+ transients (de
Cerqueira et al, 2011).
Using the whole-cell configuration of the patch-clamp technique, thymol (1
µM-1 mM range), inhibited peak amplitude of L-type Ca2+ current in NG108-15
cells (Huang et al, 2005) and rat skeletal muscle fibers (Szentandrassy et al, 2003)
and ventricular cardiomyocytes (Magyar et al, 2002). Similarly, in isolated cardiac
myocytes, both eugenol (Sensch et al, 2000) and carvacrol (Magyar et al, 2004)
caused inhibition of peak L-type Ca2+ currents with IC50 of 226 µM and 98 μM,
respectively. Eugenol was also examined on cloned T-type Ca2+ channel isoforms
expressed in HEK293 cells, using whole-cell patch clamp. In this study, eugenol
caused inhibition of Cav3.1, Cav3.2, and Cav3.3 currents in a concentration-
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dependent manner (Seo et al, 2013). Another recent study (Peixoto-Neves et al,
2014) demonstrated that eugenol dilates arteries in a concentration-dependent
manner and inhibits voltage-dependent Ca2+ currents in isolated cerebral artery
smooth muscle cells. Another monoterpene, linalool has also been shown to suppress
voltage-gated Ca2+ currents in retinal horizontal cells and Purkinje cells (Narusuye et
al, 2005). Collectively, these findings suggest a significant inhibitory action of some
monoterpenes on L-type Ca2+ channels and may provide a structural template for the
development of new L-type Ca2+ channel blockers.
1.4.3. Potassium channels
Voltage-dependent K+ channels are activated by changes in membrane
potential and function to repolarize the membrane potential and function to
repolarize the membrane potential to resting levels by selectively allowing passage
of K+ ions down its electrochemical gradient across the cell membrane. Voltagedependent K+ channels are widely distributed in mammalian tissues and play
important physiological roles (for recent reviews, see Gonzalez et al, 2012; Jan &
Jan, 2012; Nerbonne, 2014; Oudit et al, 2004). The functional roles of voltagedependent K+ channels include setting the duration of action potentials and the
interspike interval during repetitive firing in neurons and in the heart, secreting K+ in
epithelia and adjusting the contractile tone of the smooth muscle. Voltage-dependent
K+ channels consist of four subunits. The tremendous diversity of voltage-dependent
K+ channels can be attributed to the large number of different genes present,
auxiliary β-subunits and metabolic regulation (Latorre et al, 2013).
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There are very few studies exploring the effect of monoterpenes on voltagedependant K+ channels. Thymol had an inhibitory effect on transient outward
potassium currents in a concentration-dependant manner in canine and human
ventricular myocytes (Magyar et al, 2002). Thymol caused inhibition of K+ currents
with an EC50 of 60.6 µM, however, the kinetics of K+ currents were not much altered
by thymol. These effects developed rapidly (within 0.5 min) and were readily
reversible (Magyar et al, 2002). Similarly inhibition of K+ current by thymol has also
been reported in skeletal muscle fibers (Szentandrassy et al, 2003). Another study
using whole-cell patch clamp reported that eugenol also inhibits voltage-gated K+
currents in rat trigeminal ganglion neurons and human Kv1.5 currents stably
expressed in Ltk(-) cells in a concentration-dependent and reversible manner (Li et
al, 2007). In addition to voltage-dependent K+ currents, Ca2+-activated K+ currents
have also been shown to be modulated by monoterpenes. For example, Ca2+activated K+ channels were activated by menthol in human glioblastoma cells
(Wondergem & Bartley, 2009) and by thymol in pituitary GH3 cells (Huang et al,
2005).
1.4.4. Non-selective cation channels
Transient Receptor Potential channels (TRP channels) are a group of non-selective
cation channels. The founding member of this family was discovered in Drosophila
and divided into six subfamilies, named C, V, M, A, P, and ML, on the basis of
amino acid sequence homology: canonical, vanilloid, melastatin, ankyrin repeat,
polycystins, and mucolipins, respectively (Clapham & Squire, 2009). TRP channels
function as cation channels that mostly increase intracellular Ca2+ levels. However,
only a few of the TRPs are highly Ca2+selective, and exhibit a variety of gating
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mechanisms. They are activated by variable stimuli like changes in temperature, pH,
and osmolarity, and are modulated by growth factor and G-protein-coupled receptor
pathways. These channels are involved in diverse physiological processes, such as
photoreception, pain perception, mechanosensation, thermosensation, cell growth,
secretion, and ion channel regulation (Freichel & Flockerzi, 2007).
A major difficulty in the study of TRP channels is the lack of specific
pharmacological agents that modulate most members of the TRP superfamily.
Nevertheless, exploring the effect of different monoterpenes has recently been a
highly attractive area for researchers in this field. Several reports screened the
activity of a wide range of structurally related monoterpenes on selected TRP
channel subtypes. One of these studies focused on TRPV3, a thermosensitive ion
channel expressed predominantly in the skin and neural tissues, and screened a
selection of monoterpenoid compounds using whole cell patch clamp techniques.
Monoterpene camphor is a known agonist of TRPV3 (Moqrich et al, 2005). Out of
33 screened compounds, six monoterpenes significantly more potent than camphor,
were identified: 6-tert-butyl-m-cresol (290%), carvacrol (265%), dihydrocarveol
(255%), thymol (245%), carveol (150%) and borneol (118%). Dose-response curves
for these six compounds were determined using voltage clamp techniques in TRPV3
expressing Xenopus leavis oocytes. Their EC50 values were found to be up to 16
times lower than that of camphor (Vogt-Eisele et al, 2007). Another study examined
the effect of thymol and other related compounds on human TRPA1 channels, a TRP
channel subtype that is known to respond to noxious cold (Story et al, 2003).
Thymol (6.25 and 25 µM) caused depolarization of HEK293 cells expressing
hTRPA1 determined by a strong increase in dye fluorescence using a Ca2+ imaging
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assay. Cinnamaldehyde, as a positive control, showed a similar profile and both
compounds showed no activity on the parental HEK293 cells, indicating specific
activity on hTRPA1 channels (Lee et al, 2008). In the same study, the direct effects
of thymol on TRPA1 mediated currents were tested using whole-cell voltage clamp.
Thymol activated TRPA1 currents with an EC50 of 127 µM, but this activation was
eliminated upon repeated application of thymol due to channel desensitization.
Desensitization by thymol reduced the response to AITC (allyl isothiocyanate, a
known agonist), indicating that both compounds act on the same channels (Lee et al,
2008).
In an attempt to identify the pharmacological mechanism of its
antinociceptive effect, actions of carvone were examined using DRG neurons and
TRPV1-expressing HEK293 cells in Ca2+ imaging experiments. In this study,
carvone stimulated a significant increase in intracellular Ca2+ levels (Goncalves et al,
2013). This increase in cytosolic Ca2+ level was completely abolished when cells
were preincubated with Ca2+-free bath solution, 5 µM ruthernium red (non-specific
antagonist of TRP channels) and

10 µM of capsazepine (specific TRPV1

antagonist), confirming that the effects of carvone were mediated by TRPV1
activation (Goncalves et al, 2013). Collectively, these results suggest that
monoterpenes can be useful for the development of new drugs involving TRP
channel-related pathological conditions.
1.4.5. GABA and Glycine receptors
Receptors for γ-amino butyric acid (GABA) and glycine (Gly) are pentameric
ligand-gated ion channels that respond to inhibitory neurotransmitters by opening a
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chloride-selective central pore (Minier et al, 2013). GABA is the major inhibitory
neurotransmitter in the central nervous system. GABA is synthesized in GABAergic
neurons and released in the synaptic cleft in response to an action potential. Upon its
release, GABA acts at two different types of receptors: the ionotropic
GABAA receptors

(chloride-selective

ion

channels)

and

the

metabotropic

GABAB receptors (G-protein coupled receptors). In case of GABAA receptor,
binding of GABA triggers a conformational change in the receptor leading to the
opening of the pore. This causes a state of hyperpolarization and therefore neural
suppression (Minier et al, 2013). Glycine receptors are found predominantly in the
spinal cord and brain stem. Glycine released from nerve endings act by binding to
the glycine receptor (GlyR) and cause opening of chloride channels leading to
hyperpolarization and subsequent neural suppression (Ashcroft, 2000).
Several monoterpenes have been used in conventional medicine as anesthetic
and anxiolytic agents (Bakkali et al, 2008; Denner, 2009). These effects of
monoterpenes lead to the investigation of these compounds on GABA and glycine
receptors. Among the monoterpenes, the effect of menthol on GABA current was
extensively studied by different groups of researchers using various in vitro and in
vivo models. In an earlier study screening the effects of monoterpenoid alcohols and
ketones on recombinant human GABAA (α1β2γ2s) and glycine (α1 homomers)
receptors expressed in Xenopus oocytes, GABA-induced currents were enhanced by
coapplication of 10–300 µM of monoterpenes in the following order, (+)-menthol >
(-)-menthol > borneol > menthone = camphor = carvone (Hall et al, 2004). However,
application of menthol alone (up to 1 mM) did not induce direct current indicating no
agonistic activity of menthol. Menthol, 100 µM, reduced EC50 values for GABA and
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glycine from 82 to 25 µM and from 98 to 75 µM respectively, indicating that
menthol acts as a positive modulator of GABA and glycine inhibitory currents (Hall
et al, 2004). In contrast to menthol, application of diastereomers of thujone inhibited
GABAA receptor currents. Similarly, another group of researchers investigated the
effect of menthol and other monoterpenes in Xenopus laevis oocytes expressing
GABAA receptors (Watt et al, 2008). They found that upon co-application of submaximal (EC20) GABA concentrations, the current sizes were enhanced
concentration-dependently in the following order: (+)-menthol (e.g. by ~2-fold at 50
μM) > isopulegol > isomenthol > α-terpineol >> cyclohexanol (Watt et al, 2008). In
this study, they also compared the effect of (+)-menthol to clinically used anesthetics
such as propofol. At 2 μM propofol and 50 μM (+)-menthol, the level of GABA
EC20 current enhancement was almost similar (119% and 96.2%, respectively).
When co-applied, currents directly activated by 50 μM propofol were significantly
inhibited (up to 26%) by 50 μM (+)-menthol suggesting that menthol and propofol
compete for a common binding site on GABAA receptors. In an in vivo tadpole assay
(based on using gradually increasing concentration of the anesthetic agent and
examining loss of righting reflex of the tadpole), addition of (+)-menthol resulted in
an anesthetic effect with an EC50 of 23.5 μM (~10-fold less potent anesthesia than
propofol) (Watt et al, 2008). In radioligand binding experiments, it was found that
only (+)-menthol, among the five stereoisomers analyzed, was active, stimulating the
binding of [3H]-flunitrazepam, an allosteric GABAA receptor ligand, in a dosedependent manner (Corvalan et al, 2009). In another radioligand binding study in
housefly

head

membrane

preparations,

specific

binding

of

[3H]-

tbutylbicycloorthobenzoate (TBOB), a non-competitive inhibitor of picrotoxin, was
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enhanced by 1,8-Cineole, carvacrol, citronellic acid, pulegone and thymol. On the
other hand, four monoterpenoids, camphor, menthol, safrole and vanillin,
significantly inhibited the [3H]-TBOB binding (Tong & Coats, 2012).
Another study showed that menthol reduced the excitation of cultured rat
hippocampal

neurons

and

suppressed

the

epileptic

activity induced

by

pentylenetetrazole injection and electrical kindling in vivo (Zhang et al, 2008). It was
found that menthol not only enhanced the currents induced by low concentrations of
GABA but also directly activated GABAA receptors in hippocampal neurons in
culture. Furthermore, in the CA1 region of rat hippocampal slices, menthol enhanced
tonic GABAergic inhibition although phasic GABAergic inhibition was unaffected.
Another study examined the effects of menthol on respiratory rhythm generation in
brainstem–spinal cord preparations isolated from newborn rats (Tani et al, 2010).
The results suggested that menthol has potent inhibitory action on burst generation of
pre-inspiratory neurons due to direct activation of tonic GABAA channels by
menthol. In another recent investigation, the actions of menthol on GABAA receptormediated currents in intact midbrain slices were examined (Lau et al, 2014). Wholecell voltage-clamp recordings in periaqueductal grey (PAG) neurons in midbrain
slices were used to determine the effects of menthol on GABAA receptor-mediated
phasic inhibitory postsynaptic currents (IPSCs) and tonic currents (Lau et al, 2014).
Menthol (150-750 μM) produced a concentration-dependent prolongation of
spontaneous GABAA receptor-mediated IPSCs, but not non-N-Methyl-D-Aspartate
(NMDA) receptor-mediated currents. Menthol actions were unaffected by TRPM8
and TRPA1 antagonists, tetrodotoxin and the benzodiazepine antagonist, flumazenil.
Menthol also enhanced a tonic current, which was sensitive to the GABA A receptor
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antagonists, picrotoxin and bicuculline. These results suggested that menthol
positively modulates both synaptic and extrasynaptic populations of GABAA
receptors in native neurons of CNS.
Thymol is another monoterpene that has been tested on GABAA receptors.
One group used primary cultures of cortical neurons to examine the effect of thymol
on native GABAA receptors (Garcia et al, 2006). They showed that thymol enhanced
GABA-induced chloride influx at concentrations lower than those exhibiting direct
activity in the absence of GABA and that thymol is a positive allosteric modulator of
GABAA receptors as it enhanced [3H]flunitrazepam binding with an EC50 = 131 µM.
Interestingly, both bicuculline, a competitive GABA receptor antagonist, and
picrotoxin, a non-competitive antagonist, were able to completely inhibit this
increase in [3H]flunitrazepam binding induced by thymol. The thymol structural
analogues menthol and cymene, which lack an aromatic ring or a hydroxyl group,
did not affect [3H]flunitrazepam binding (Garcia et al, 2006).
In another investigation (Reiner et al, 2009), researchers determined and
correlated several lipophilic parameters for GABAergic agents and three other
related phenolic monoterpenes (eugenol, carvacrol and chlorothymol). The results of
their correlation studies demonstrated the high capacity of these monoterpenes to
interact with phospholipid membrane phases, which can be predicted by
physicochemical parameters such as logP(o/w). Finally, the fact that all monoterpenes
studied were able to interact with membranes suggested that some alteration of the
GABAA receptor lipid environment can be exerted by thymol and other phenolic
compounds (Reiner et al, 2009). In another study (Reiner et al, 2013b), researchers,
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using Langmuir films, analyzed the effects of thymol on the molecular properties of
the membranes. All the compounds studied were able to expand phospholipid films,
by their incorporation into the monolayer membranes. Epifluorescence images
revealed the presence of monoterpenes between phospholipid molecules, probably at
the head-group region. The results of this study indicated that the thymol and other
phenols studied were able to interact with membranes, suggesting that their
biological activity could be the combined result of their interaction with specific
receptor proteins and with their surrounding lipid molecules (Reiner et al, 2013b). In
a recent study on the native GABAA receptor using primary cultures of cortical
neurons, Reiner et al., (2013b) investigated the effects of these compounds on the
micro viscosity of membranes by means of fluorescence anisotropy. Phenolic
monoterpenes such as carvacrol, chlorothymol, and eugenol were able to enhance the
binding of [3H]flunitrazepam with EC50 values in the µM range and to increase the
GABA-evoked Cl- influx in a concentration-dependent manner, both effects being
inhibited by the competitive GABAA antagonist bicuculline, strongly suggesting that
the compounds studied are positive allosteric modulators of this receptor (Reiner et
al, 2013a). Collectively, these results indicate that thymol and other monoterpenes
can modulate the function of GABAA receptors by directly acting on the receptors
and also altering the biophysical characteristics of lipid membranes. Importantly,
some studies suggest that thymol also acts on G-protein coupled receptors such as
GABAB (Parker et al, 2014) and α1, α2, and β-adrenergic receptors (Beer et al,
2007). (+)-Borneol, a bicyclic monoterpene used for analgesia and anaesthesia in
traditional Chinese and Japanese medicine, was also tested alone and with GABA at
recombinant human α1β2γ2L GABAA receptors expressed in Xenopus laevis oocytes
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using the two-electrode voltage-clamp technique. (+)-Borneol (EC50 248 µM) and ()-borneol (EC50 237 µM) were able to greatly enhance the effect of low
concentrations of GABA. At high concentrations (>1.5 mM) both enantiomers
directly activated GABAA receptors indicating weak partial agonist activity (Granger
et al, 2005).
The effects of monoterpenes on the glycine receptors are less well
understood. Menthol was examined for its effect on homomeric α1 glycine receptors
expressed in Xenopus oocytes (Hall et al, 2004). The results of this study revealed
that both (+) and (-) enantiomers of menthol could enhance glycine (EC20 = 50µM)induced currents (Hall et al, 2004).
1.4.6 Serotonin type-3 receptors
Serotonin type-3 (5-HT3) receptors are another member of the ligand-gated
ion channels that belong to the Cys-loop superfamily. The effects of menthol on
these receptors have been described in several studies (Ashoor et al, 2013b; Heimes
et al, 2011; Walstab et al, 2014). Heimes et al., (2011) tested the effect of menthol
on 5-HT3 receptors using three different in vitro models: [14C]guanidinium influx
into N1E-115 cells which express 5-HT3 receptors, isotonic contractions of the
isolated rat ileum and equilibrium competition binding studies using a radioactively
labelled

5-HT3

receptor

antagonist

([3H]GR65630).

Menthol

inhibited

[14C]guanidinium influx through 5-HT3 receptor channels as well as contractions of
the ileum induced by 5-HT. Menthol, however, was not able to displace [3H]
GR65630 from 5-HT3 binding sites. In this study, it was concluded that menthol
exerts its well-known antiemetic effects at least partly by acting on the 5-HT3
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receptor ion-channel complex by binding to a modulatory site distinct from the 5-HT
binding site. In another study, Ashoor et al., (2013) investigated the effects of
menthol on the function of human 5-HT3 receptors expressed in Xenopus laevis
oocytes. 5-HT-evoked currents were reversibly inhibited by menthol in a
concentration-dependent (IC50 = 163 μM) manner (Ashoor et al, 2013b). The effects
of menthol developed gradually, reaching a steady-state level within 10-15 minutes
and did not involve G-proteins, since GTPγS activity remained unaltered and the
effect of menthol was not sensitive to pertussis toxin pretreatment. The actions of
menthol were not stereoselective as (-), (+), and racemic menthol inhibited 5-HT3
receptor-mediated currents to the same extent. The maximum inhibition observed for
menthol was not reversed by increasing concentrations of 5-HT. Furthermore,
specific binding of the 5-HT3 antagonist [3H]GR65630 was not altered in the
presence of menthol, indicating that menthol acts as a non-competitive antagonist of
the 5-HT3 receptor. Finally, 5-HT3 receptor-mediated currents in acutely dissociated
nodose ganglion neurons were also inhibited by menthol (Ashoor et al, 2013b). The
results of this study demonstrated that menthol, at pharmacologically relevant
concentrations, is an allosteric inhibitor of 5-HT3 receptors. In another study the
impact of menthol on human recombinant homomeric 5-HT3A- and heteromeric 5HT3AB receptors in HEK293 cells was determined by radioligand binding, a
luminescence-based Ca2+ assay, and a membrane potential assay (Walstab et al,
2014). Menthol enantiomers inhibited 5-HT3A and 5-HT3AB receptor with IC50 of 179
and 2041 µM for (-) menthol and 369 and 819 µM for (+) menthol suggesting
enantiomer selectivity (Walstab et al, 2014). These studies indicate clearly that
monoterpene menthol is an allosteric inhibitor of 5-HT3 receptors. In another study,
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carvacrol and thymol showed allosteric agonist activity on human homomeric 5-HT3
receptors expressed in Xenopus oocytes and also lower concentrations of these
monoterpenes potentiated submaximal concentrations of 5-HT. Interestingly, both
effects were species-specific as they were completely absent when using mouse 5HT3 receptors (Lansdell et al, 2015). The effects of other monoterpenes on the
functional properties of 5-HT3 receptors are currently unknown and require further
investigation.
1.5. Monoterpenes and the Cholinergic System
1.5.1. Cholinergic system
Acetylcholine (ACh) is the principal neurotransmitter in the parasympathetic
autonomic nervous system as well as inside the central nervous system (CNS). The
neurochemical events in the life cycle of ACh are shown in Figure 1.4. Synthesis of
ACh is dependent on the availability of choline. There is very little de novo choline
synthesis in cholinergic neurons; therefore, the pool of choline is built mainly from
dietary sources. Choline is loaded inside the cholinergic neurons from the
extracellular space by two transport systems (Westfall, 2009). One of them is a
widely distributed, low-affinity, sodium independent transporter while the other
transporter is a high-affinity, sodium and chloride dependent choline transporter
system. The latter exists predominantly in cholinergic neurons and provides choline
for ACh synthesis (Westfall, 2009). ACh is synthesized in the cytosol from choline
and acetylCoA (AcCoA) by the choline acetyltransferase (ChAT) enzyme and then
loaded into storage vesicles by the vesicular acetylcholine transporter (VAT) which
can be inhibited by vesamicol. When depolarized by an action potential, voltage-
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gated Ca2+ channels are opened and the presynaptic neuron releases the stored ACh
into the synaptic cleft, where it interacts with muscarinic (mAChRs) or nicotinic
acetylcholine receptors (nAChRs). Once ACh dissociates from the receptors, it is
rapidly hydrolyzed by acetlycholinesterase (AChE), which breaks down ACh into
acetate and choline. Choline is then taken back into the presynaptic neuron by
sodium-dependent choline transporter (CHT) to be recycled. CHT can be inhibited
by hemicholinium drugs. Most cholinergic synapses are highly supplied with
acetylcholinesterase therefore,

the half-life of acetylcholine molecules in the

synapse is extremely short (a fraction of a second) (Katzung, 2012). Reuptake and
availability of choline is the rate-limiting step in ACh synthesis.

32

Figure 1.4: Schematic illustration of a cholinergic junction. Sodium-dependent choline
transporter (CHT), acetyl-CoA (AcCoA), choline acetyltransferase (ChAT). Vesicular acetylcholine
transporter (VAT), Peptides (P), adenosine triphosphate (ATP), SNAPs, synaptosome-associated
proteins; VAMPs, vesicle-associated membrane proteins. (From: Chapter 6. Introduction to
Autonomic Pharmacology, Basic & Clinical Pharmacology, 12e, 2012)

Inside the CNS, there are specialized cholinergic neurons. Early attempts to
localize these neurons were based on immunohistochemical methods to localize
(AChE) enzyme, but this was not specific for specialized cholinergic neurons as it
revealed cholinoceptive neurons as well. In more recent studies, localization of
ChAT-immunoreactive cell bodies was considered as more selective and specific for
cholinergic neurons (Cuello, 2009). The main central cholinergic cell groups and
pathways are shown in Figure 1.5. In the human CNS, the cholinergic system
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involves a highly complex network that has three main components, the first two
components are diffuse, divergent projection systems that innervate wide areas of the
brain. They include: (1) projections from nuclei of the basal forebrain; these include
the medial septal nucleus, the nucleus basalis of Meynert (a site associated with
profound degeneration in Alzheimer's disease), the vertical nucleus of the diagonal
band and the horizontal limb of the diagonal band nucleus, which innervate the
hippocampus, most cortical regions and some subcortical nuclei. Although this
system is located in separate areas of the brain, they are usually referred to as the
magnocellular basal forebrain cholinergic system (Mesulam et al, 1983). (2) The
pedunculopontine-lateral dorsal tegmental projections from the brainstem to the
thalamus, midbrain and other brainstem regions. The third central cholinergic
component includes (3) interneurons in the neostriatum (most abundant) and
correspond to the caudate nucleus-putamen complex. Also the ventral striatum has
cholinergic interneurons in the nucleus accumbens and islands of Calleja (Everitt &
Robbins, 1997; Perry et al, 1999).
Based on the complex nature of cholinergic neurotransmission in the human
CNS, cholinergic neurons have been shown to play roles in diverse brain functions
such as sleep, cognition, memory, motor control, and sensory processing (Scarr et al,
2013). For several decades, the CNS cholinergic system was suspected to play an
important role in memory and learning.
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Figure 1.5: A schematic representation of the human central cholinergic system —striatal
interneurons not shown. Adapted from (Felten, D.L., and Shetty, A.N. (2010). Netter’s Atlas of
Neuroscience. 2nd Edition. Philadelphia: Saunders; Elsevier, 438).

One of the most important early studies demonstrating central cholinergic
function was carried out by Drachman and collaborators in healthy young human
subjects. They showed that subjects who were treated with low dose scopolamine, a
muscarinic antagonist, showed similar memory and cognitive decline aged subjects
(Drachman et al, 1980). There is experimental evidence indicating that the basal
forebrain cholinergic neurons do participate in attention, learning, and memory
functions (Gibbs & Johnson, 2007; Leanza et al, 1996; Wrenn & Wiley, 1998).
Several earlier investigations have highlighted the role of the cholinergic system in
conditioning and sensory learning (Deiana et al, 2011; Robinson et al, 2011). The

35

general observation is that blockade of both muscarinic and nicotinic receptors led to
widespread impairments in either acquisition learning or long-term memory
processing, and this can be reversed by boosting levels of ACh. Consistently,
stimulation of either muscarinic (mainly M1) or nicotinic (predominantly α7)
receptors was beneficial for learning and memory and has been suggested to be
valuable in the treatment of neurodegenerative or psychiatric disorders with
cognitive impairment (Deiana et al, 2011; Robinson et al, 2011). Researchers have
shown that variable performance of the central cholinergic system in the elderly,
measured by assessing the AChE enzyme activity, is closely linked and can underlie
the inter-individual variability in memory function (Richter et al, 2014). Therefore,
cholinergic dysfunction can be considered an early hallmark even before onset of
dementia.
The nicotinic α7 receptor subtype was found to be involved in working
memory, whereas the α4β2 subtype has been linked to tests of attention. In addition
to learning and memory, nicotinic receptors are also associated with the modulation
of depression and anxiety (Graef et al, 2011).
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1.5.2. Nicotinic receptors
Nicotinic acetylcholine receptors (nAChRs) belong to a large family of
ligand-gated ion channels that include also GABAA receptors, serotonin 5-HT3
receptors and glycine receptors. Several structural features are conserved in all
members of this gene family, most notably a disulfide-linked sequence of fifteen
amino acids that constitutes what is called the ‘‘signature Cys-loop’’ and the whole
family is referred to as the ‘‘Cys-loop superfamily’’ of ligand-gated ion channels
(Gotti et al, 2009). The nicotinic receptor was the first pharmacologic receptor to be
purified and the cDNAs encoding its subunits cloned, therefore they are considered
as prototype for the ligand-gated ion channel family (Itier & Bertrand, 2001).
Nicotinic receptors are widely distributed in the central and peripheral nervous
systems. In skeletal muscle they are found in a high density at the motor end plate. In
ganglia, the primary nicotinic receptor is found on the postsynaptic dendrite and
nerve cell body. In the CNS, the majority of receptors are presynaptic, so they have
regulatory function as they control the release of other transmitters or work as
autoreceptors in cholinergic neurons (Gotti et al, 2006; Taylor, 2012).
Overall, nicotinic receptors are ionotropic receptors that exist as pentamers
with intrinsic cation-permeable pores that are gated by the binding of ACh. The five
subunits of the receptors can be identical (homomeric) or variable (heteromeric).
Muscle-type ACh receptors were first isolated from electrical organs of fishes such
as Torpedo marmorata (Karlin, 2002; Unwin, 1998). The receptors in Torpedo
electric tissue and in fetal muscle are heteropentamers, with subunit composition of
α2βγδ (Figure 1.6). In adult muscle, the receptor contains an ε subunit in place of the
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γ subunit and has a greater single-channel conductance and a smaller mean singlechannel-open time than fetal receptor (Hurst et al, 2013). There are nine other
neuronal α subunits (α2–α10) and three known neuronal β subunits (β2–β4); the α
subunit constitutes the principal component for binding site, while the β subunit is a
complementary component of the receptor (Hurst et al, 2013). Some neuronal α
subunits (e.g., α7) form functional homopentamers. Different regions of the
peripheral and central nervous system express different combinations of the neuronal
subunits (Karlin, 2010).
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Figure 1.6: Structure of nicotinic ACh receptors. a | The structure of each subunit of
nAChRs consists of β-strands, four transmembrane α-helices segments (M1-M4), a variable
intracellular loop between M3 and M4, and an extracellular carboxy-terminus. The extracellular
domain carries the acetylcholine–nicotine binding sites at the boundary between subunits. The
number of binding sites per pentamer is variable, depending on its composition, from two (in muscle
nAChRs or brain α4β2 nAChRs) to five (in the α7 homopentamer). Sites for allosteric modulators are
located in the transmembrane domain. b | A schematic representation of the quaternary structure,
showing the arrangement of the subunits in the muscle-type receptor, the location of the two
acetylcholine-binding sites (between an alpha- and a gamma-subunit, and an alpha- and a deltasubunit), and the central cation-conducting channel. c | A cross-section through the 4.6-Å structure of
the receptor determined by electron microscopy of tubular crystals of Torpedo membrane embedded
in ice. Dashed line indicates proposed path to binding site (Adapted from Karlin, 2002).

1.5.3. Neuronal nicotinic receptors
The most abundant subtypes of nicotinic receptors in the brain are the low
affinity α7 homomeric and high affinity α4β2* heteromeric nAChRs (Figure 1.7).
Different subunit types are distributed in most central cholinergic areas as shown in
table (1). Due to variable types of subunits, heteromeric nAChRs are rather complex
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as they can contain two or three alpha subunits co-assembled with two or three beta
subunits. For example, α4β2 nAChRs can be formed either as [(α4)2(β2)3] or as
[(α4)3(β2)2]. This variability causes many differences between the various forms of
nAChRs. In the previous example, [(α4)2(β2)3] nAChRs showed very high
sensitivity to ACh that is almost 100 times greater than that of [(α4)3(β2)2] nAChRs
(Moroni et al, 2006; Zwart & Vijverberg, 1998). In addition, some subtypes
identified express more than one type of alpha and/or beta subunit. For example, the
α4α6β2β3* nAChR was detected in midbrain dopaminergic neurons (Liu et al,
2012).

Figure 1.7: Schematic presentation of homomeric and heteromeric nAChRs.
(A) Homomeric receptors consist of subunits only and usually have low affinity for agonist.
To date, only mammalian α7, α9, and α10 (not shown) subunits may form functional homomers. (B)
The majority of high affinity nAChRs are heteromeric and consist of a combination of α and β
subunits. Importantly, multiple α subunits may coassemble with multiple β subunits in the pentameric
nAChR complex (illustrated here by α4α6β2β3). ACh binding sites are depicted as red triangles
(Adapted from Hendrickson et al, 2013).

The most abundant homomeric α7 nAChRs has been extensively studied
owing to its unique physiological and pharmacological properties. It is exclusively
characterized by high permeability to Ca2+ (PCa:PNa of ≥ 10 compared to 3-4 for
most other nAChRs) and rapid desensitization. The α7 subunit is expressed at high
levels in the hippocampus and hypothalamus (Seguela et al, 1993). Significant
proportion of α7 nAChRs are located on presynaptic terminals where they facilitate

40

Ca2+ dependent release of neurotransmitters. This may occur indirectly as a result of
Na+ influx causing membrane depolarization and activation of voltage-gated
Ca2+ channels or directly by Ca2+ influx through the nAChR itself (Albuquerque,
2009). Eventual increase of intracellular Ca2+ level upon nAChR activation makes
these receptors relevant for the regulation of other Ca2+-mediated events such as cell
excitability, activation of second messenger pathways, gene expression and cell
differentiation (Berg & Conroy, 2002). The change in the pattern of α7 nAChR
expression over time suggests that these receptors play a role during brain
development. Their concentration is high during the stage of synapse formation
(Gotti & Clementi, 2004). During development, α7 nAChRs are also expressed in
non-neuronal

cell

types,

including

muscle,

glia,

epithelial

cells,

and

β3

β4

chondrocytes (Berg & Conroy, 2002; Gotti & Clementi, 2004).
α3
Cortex
Frontal
Temporal
Parietal
Midbrain
Hippocampus
Entorhinal Cx
Pyramidal cells
Dentate gyrus
Basal ganglia
Putamen
Caudate
Cerebellum

α4

•
•
•
•

•
•
•
•
•
•
•
•

•
•
•

•
•
•

•

α5

α6

α7
•
•

•

•
•

β2

•
•
•
•

•
•
•
•
•
•
•

•
•
•

•
•
•

•
•
•
•

Table 1: Nicotinic receptor subunit protein expression in human brain (Adapted from Gotti &
Clementi, 2004)

•
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1.5.4. Nicotinic receptors and monoterpones
As mentioned earlier, being one of the most widely distributed nicotinic
receptor subtypes in different higher brain areas, α7 nAChRs have been proven to be
involved in many neural physiological and pathological conditions. There is
considerable interest in finding selective ligands for nAChRs individual subtypes. In
case of homomeric α7 nAChRs, many reports have indicated the beneficial effects of
activation of these receptors in improvement of cognitive deficits of patients with
schizophrenia and Alzheimer's disease (Bourin et al, 2003; D'Andrea & Nagele,
2006; Deutsch et al, 2014; Leiser et al, 2009; Levin, 2002; Ripoll et al, 2004;
Thomsen et al, 2010; Wallace & Porter, 2011; Young & Geyer, 2013) .
Fewer studies, mostly in mice and rats, have demonstrated that α7 nAChRs
antagonism showed anti-depressant activity using several common tests of
antidepressant efficacy including the forced swimming test and tail suspension test
(Andreasen et al, 2009; Rabenstein et al, 2006). Clinical data elucidated that the nonselective nAChR antagonist, mecamylamine, reduces depression-like symptoms
suggesting that targeting nAChRs could be a reasonable strategy for developing
novel antidepressant medications (Shytle et al, 2000; Shytle et al, 2002).
Interestingly, the α7 nAChRs have also been suggested to play an important role in
both central and peripheral mechanisms involved in eating behavior and energy
balance (reviewed in details by McFadden et al, 2014).
In the context of searching for selective novel agents that modulate the
activity of nAChRs, natural phytochemicals have proven to be a good source at least
for structural models (Daly, 2005; Romanelli et al, 2007). Regarding monoterpenes,
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only few studies have been performed to screen the effects of the monoterpenes on
nicotinic receptors. Park and co-workers tested the of effect of camphor (Park et al,
2001) and borneol (Park et al, 2003) on catecholamine secretion in bovine adrenal
chromaffin cells. Both compounds reduced [3H]norepinephrine secretion induced by
a nAChR agonist, 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP), with similar
IC50 values (70 µM). To confirm that this effect is mediated by nAChRs, cytosolic
Ca2+ and Na+ levels were measured upon treatment of the cell with DMPP alone and
in the presence of monoterpenes. The rise of [Ca2+]i and [Na+]i, an essential step for
the release of catecholamines by nAChRs activation, was inhibited with an IC 50 of
88 and 19 µM for camphor and 56 and 49 µM for borneol, respectively. Binding
assay of [3H]nicotine to nAChRs showed that these monoterpenes did not alter the
binding of nicotine indicating that their binding site is distinct from nicotine's and
ACh binding sites. However, another monoterpene, carvacrol was examined on
nAChRs of housefly and showed non-competitive concentration dependent
inhibition of [14C]-nicotine binding (Tong et al, 2013).
In earlier studies, it was shown that menthol is an antagonist of nAChRs as
well. Hans and co-workers studied the effect of (-)-menthol on nicotine induced
current through nAChRs recorded in rat trigeminal neurons (Hans et al, 2012).
Menthol showed reversible and concentration-dependent inhibition of nAChRs.
Single channel and whole-cell recordings from recombinant human α4β2 nAChR
expressed in HEK tsA201 cells demonstrated that (-)-menthol is a negative allosteric
modulator of this nicotinic subtype (Hans et al, 2012). The effect of menthol was
also examined on another subtype, α7 nAChRs, expressed in Xenopus oocytes by
recording ACh-induced currents using the two electrode voltage clamp technique.
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Racemic, (-) and (+) forms of menthol caused concentration-dependent, noncompetitive inhibition of α7 nAChRs. Consistent with these results, experiments
done on neural cells (PC12) endogenously expressing α7 nACh receptors
demonstrated that menthol attenuates α7 mediated Ca2+ transients in the cell body
and neurite (Ashoor et al, 2013a).
Drug development efforts have recently focused on direct manipulation of α7
and α4β2 nAChRs. Monoterpenes could be helpful in better understanding of factors
influencing these nicotinic subtypes and their function and may provide specific drug
candidates or at least lead structures for further design of monoterpene-based
compounds.
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Chapter 2: Aims and Objectives
Our main objective was to investigate the effects of carveol and other related
monoterpenoids on the functional properties of 7 nACh receptors. In all
experiments, homomeric human 7 nACh receptors were expressed heterologously
in a Xenopus oocyte expression system. This expression system is convenient for
assaying the actions of tested compounds on cloned receptors for the following
reasons. 1) Procedures for acquiring and maintaining oocytes are well established.
Therefore, large number of efficiently expressing oocytes can be easily obtained on a
routine basis for the intended experiments. 2) Two-electrode voltage clamp allows a
relatively high throughput assay, so several cells can be screened on a daily basis. 3)
Recordings using two-electrode voltage clamp can be stable over long periods of
time, which makes it particularly useful for analyzing properties that require long
protocols, such as slow time course of drug action.
In the present study, several monoterpenes were screened to test their effects
on the activity of human 7 nACh receptor expressed in Xenopus oocytes. In order
of fulfil this goal, the following experiments were done:
1. Functional expression of human α7 nACh receptor in Xenopus oocytes.
2. Exploring the effects of the selected monoterpenes on the function of human α7
nACh receptor.
3. Defining voltage-dependence of cavoel's action on the α7 nACh receptor.
4. Investigating the involvement of cytosolic calcium in the effects of carveol on α7
nACh receptor.
5. Determination of the binding site of carveol in the α7-nACh receptor.
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Chapter 3: Materials and Methods
3.1 Animals and materials
3.1.1 Animals: Female Xenopus laevis
Mature female African clawed frogs (Xenopus laevis) were purchased from
Xenopus Express, Haute-Loire, France (Figure3.1). They were kept in a container
(32 cm width,130 cm length and 66 cm height) filled to a height approximately 50
cm with chlorine-free water. The room temperature was maintained at 19-21°C with
a 12 hour alternate light and dark cycle. Frogs were fed twice a week with food
pellets, supplied by Xenopus Express, France. Tank-water was changed twice a
week. Animal care and handling were consistent with institutional guidelines.

Figure 3.1: An adult female Xenopus laevis.
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3.1.2 Chemicals

Compounds

Formula weight

Manufacturer / Catalogue number

Acetylcholine chloride

181.7

Sigma, USA / A6625

BAPTA
Barium chloride (BaCl2)
Benzocaine
Calcium chloride (CaCl2)
Collagenase-A (From
Clostridium histolyticum
EC.3.4.24.3)
Gentamicin reagent solution

764.68
244.28
165.2
110.9
----------

Sigma-Aldrich/ A-1076
BDH, England/R-20-25 S:45
Sigma, USA/ E-1501
Sigma-Aldrich, USA / C-4901
Roche Diagnostic Corporations
USA/ Lot number 93211521

HEPES
Hydrogen chloride (HCl)
Magnesium chloride
Magnesium sulphate
Penicillin G
Potassium chloride (KCl)
Sodium bicarbonate
(NaHCO3)
Sodium chloride (NaCl)
Sodium hydroxide (NaOH)

Conc. 50mg/ml Invitrogen Corporation/China Cat.
number 15750-060
238.3
Sigma, USA / H3375
37%
Sigma-Aldrich, USA /25.814.B
95.22
Sigma, USA / M8266
246.5
Sigma, USA / M9397
356.4
Sigma, USA / P3032
74.55
Mallinckrodt USA / 6858
84.01
Sigma, USA / S6014
58.4
40
110.04
1457.4
~8500

Sodium pyruvate
Streptomycin
α- Bungarotoxins

Sigma, USA / S-3014
Amresco, USA /
Lot. # 214613010
Sigma-Aldrich, USA /P2256
Sigma, USA / S9137
Sigma / T-0195

Table 2: Chemicals required for experiments.

3.1.3 Experimental setup
The experimental setup for electrophysiological recordings using two
electrode voltage clamp is shown in Figure 3.2 and 3.3. Two-electrode voltage clamp
(TEVC) technique was applied using a GeneClamp-500B amplifier (Axon
Instruments, Molecular Devices, Inc., Sunnyvale, CA, USA), as described previously
(Ashoor et al, 2013a) recording setup included magnetic holding devices (Kanetec
USA Corporation, Bensenville, IL, USA), two manual micromanipulators (M33;
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Märzhäuser, Wetzlar, Germany) and head-stages for voltage (HS-2A Headstage,
Gain 1 MG, Axon Instruments, Molecular Devices, Inc., Sunnyvale, CA, USA) and
current (HS-2A Headstage, Gain 10MG) attached to manipulators. Electrodes were
inserted in electrode holders and connected to the head-stages.
The perfusion apparatus consisted of perfusion tubes and bottles containing
extracellular solutions connected to the recording bath by silicon tubing (Cole
Parmer Instrument Company, I.D. 1/16 inch, O.D. 1/8 inch and WALL1/32, Vernon
Hills, Illinois, USA). Flow rate of perfusion was set to 3 to 5 ml/minute. A
multichannel perfusion system was used for drug applications included tubing (CFlex tubing, Cole-Parmer Instrument Company, I.D. 1/32 inch, O.D. 3/32 inch and
WALL1/32 inch, Vernon Hills, Illinois, USA), 50 mL glass syringes, plastic valves
and coupling devices. The drug application system was based on gravity flow by
means of a micropipette that was set at a distance of about 2-3 mm from the oocyte
position in the perfusion chamber/recording chamber (Warner Instruments LLC,
Hamden, CT, UK) designed for placing oocyte to be impaled with the
microelectrodes (Figure 3.3). In initial control studies using high K+ (20 mM)
containing solution, we determined that the response time of our recording system is
0.1 to 0.4 sec (0.32 ± 0.07 s; mean ± SEM, n=8).
An optic fiber light source was used for illumination of the recording
chamber (Fiber Lite, High Intensity Illuminator Series 180, Dolan-Jenner Industries
Inc. Boxborough, MA, USA). A Low-power stereo-dissection microscope
(Olympus, Tokyo, Japan, SZ-STB1, 100 AL0.5 X, WD186) was used for visual
observation of the recording chamber. The computer set up for recording consisted
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of a Compaq computer, (Compaq Corporation, Product of UK, City of Wynyard)
and analog-digital converter, BNC 2081 (National Instruments, Austin Texas, USA).

Figure 3.2: A photograph of the two-electrode voltage clamp used to study the alpha7 nicotinic
receptor in Xenopus oocyte. ACh solution (4,7) and perfusion solution (3) lines are connected by
tubes to the chamber (9). Micromanipulators (6) are used to control electrodes (8) to impale the
oocyte visualized using microscope (5). An amplifier (2) is used to record current traces (1);
Acquired data were stored on a computer (Prof. Murat Oz Lab).
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Figure 3.3: Illustration of the plastic chamber.The oocyte was placed on the chamber and perfused
continuously during the experiment. The suction line conveyed the solution to a waste flask.

3.1.4 Other materials

Material
Automatic nanoliter injector

Borosilicate Glass tubing for
microelectrodes.
Electrode holder

Specifications/company
Nanoject, Drummond Scientific
Company, Broomall, PA, USA
Glass Thin-walled w/filament 1.5 mm,
Catalogue number: TW150F-4, World
Precision Instrument, Sarasota, FL, USA
World Precision Instrument, Sarasota,
FL, USA

Magnetic stand and manipulators.

Catalogue number: 7739, Narishige,
Tokyo, Japan

Micro-4 Microsyringe pump controller

Model UMC4-C, World Precision
Instruments, Sarasota, FL, USA

Microfil filling syringe

World Precision Instruments, Sarasota,
FL, USA

Petri dishes

Sterilin, Newport, UK. Catalog number:
127, 60 mm
Corning pH meter model 450, Albany,
NY, USA

pH meter
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Picofuge

Stratagene, Santa Clara, CA, USA,
Catalog number: 400550

RNase free water in 1.8 mL Eppendorf
tubes

Lot number: M25-80502, Epicentre
Biotechnologies, Madison, Wisconsin,
USA
World Precision Instruments, Sarasota,
FL, USA

Silver wires

Rotomix, Type 50800,
Barnstead/Thermolyne, Dubuque, IA,
USA, Model number: M50825
Scissors, forceps, scalpels; World
Precision Instrument, Sarasota, FL, USA

Stirrer

Surgical accessories

Surgical sutures

Catgut chrom, reverse cutting 3/8 circle,
USP 4/0, SMI, DemeTech corporation,
Miami, Florida, USA

Vertical puller (Heater and solenoid
settings were adjusted to 48 and 70,
respectively, to get optimal resistance
(1-2 MΏ) glass microelectrodes)

Model 700D, David Kopf Instruments,
Tujunga, CA, USA

Table 3: Required materials

51

3.2 Solutions required
3.2.1 Preparation of Modified Barth’s Solution (MBS)
The composition of Modified Barth Solution is shown in the table below.
a. Calcium-free Modified Bath Solution.
Compounds
HEPES
KCl
MgSO4
NaCl
NaHCO3

Concentration(mM)
10
1
0.8
88
2.4

1x (weight in gram)
2.38
0.075
0.20
5.14
0.20

10x (weight in gram)
23.8
0.75
2.0
51.4
2.0

Table 4: Calcium-free MBS solution composition.

The above substances were dissolved in 1 L of distilled water and the pH of the
resulting solution was adjusted to 7.5 using NaOH.
b. Modified Barth’s Solution with Calcium.
Similar to previous composition but in addition of 2 mM CaCl2 (0.22 g for 1x and
2.2 g for 10x stock solutions), and the final solution is made up to 1L with distilled
water and pH adjusted to 7.5 with NaOH.
3.2.2 Preparation of frog's Ringer solution (ND96)
The composition of the ND96 bathing solution is given in the table below.
Compounds
NaCl
HEPES
KCl
MgCl2
CaCl2
OR BaCl2

Concentration (mM)
96
5
2
1
1.8
1.8

1x (weight in gram)
5.61
1.19
0.15
0.10
0.20
0.439

Table 5: ND96 solution.

10 x (weight in gram)
56.1
11.9
1.5
1.0
2.0
4.39
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The above weighed substances were dissolved to make 1L solution with distilled
water and the pH was adjusted to 7.5 using NaOH.
3.2.3 Preparation of oocytes storage solution

Compounds
NaCl
HEPES
NaHCO3
KCl
MgSO4
CaCl2
Penicillin G
Streptomycin

Concentration (mM)
88
10
2.4
1
0.8
2
10000U/L
10 mg/L

Weight in gram
5.14
2.38
0.20
0.075
0.20
0.22
0.019
0.01

Gentamycin
Sodium pyruvate
Theophylline

50 mg/L
2
0.5

2mL
0.22
0.09

Table 6: Oocytes storage solution.
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3.3 Methods
3.3.1 Isolation of oocytes from Xenopus laevis
Xenopus laevis female frog was anesthetized by keeping it in 1L of 0.03%
w/v benzocaine solution, prepared by dissolving 300 mg of ethyl p-aminobenzoate in
15 mL of 70 % ethanol and then adding that to 1L of cold tap water. The end point of
anesthesia was determined by failure to respond to noxious stimuli like pinching of
the lower limbs. On average it took 5-10 minutes to achieve anesthesia under the
described conditions. Experimental procedures applied in this study have been
approved by the Animal Ethics Committee of the CMHS, UAE University.
The anesthetized frog was then placed on crushed ice covered with a wet
tissue paper to avoid skin from drying out during surgery and to maintain low core
body temperature. Sterile surgical procedures were applied to remove oocytes.
Sterilized surgical tools and regular use of 70 % ethanol was employed to maintain
overall sterility. A small incision was made through the epidermal layer in the lower
abdominal area of about 1.5 cm length slightly to the left or right of the midline, and
a similar cut in the inner muscular layer. Using sterilized forceps, one to two ovarian
lobes (small clumps of oocytes) were removed and placed in a petri dish containing
Ca2+- free MBS (Figure 3.4). After removing the ovarian lobes, the muscular layer as
well as the outer skin was sutured with absorbable Catgut sutures. After surgery, the
frog was kept in a container filled with tap water and closely monitored for recovery.
After 3-4 hours of recovery, the frog was returned to the main frog container. Each
frog was utilized for three to four surgeries keeping a gap of two to three months
between each procedure.
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A

B

Figure 3.4: A: An ovarian lobe, containing oocytes at different developmental stages. B: Separating
oocytes by removal of epithelial and follicular layers manually with fine forceps.

3.3.2 Oocyte preparation
The preparation of oocytes was performed according to procedures described
earlier (Oz, Ravindran, Diaz-Ruiz, Zhang & Morales, 2003). Using fine forceps,
inner ovarian epithelium, theca, and follicular layers were removed as much as
possible to produce smaller clusters of oocytes. The resulting oocyte clusters were
then treated for one hour with 12.5 mL of collagenase solution, prepared by
dissolving 50 mg of Collagenase-A in 25 mL of Ca2+ free MBS, in a small conical
flask with continuous stirring (60-80 RPM). This procedure was repeated again for
another one hour using the remaining fresh collagenase solution (12.5 mL).
Afterwards, oocytes were washed thoroughly with Ca+2-free MBS six times, then
with Ca2+ containing MBS another six times. Subsequently, oocytes were transferred
to a petri dish containing MBS for selection using a dissecting microscope (Bunton
Instruments Co Inc., Model GSZ, Rockville, MD, U.S.A.).
Morphologically intact, healthy looking and mature oocytes (stage V–VI) are
selected. These oocytes are large in size, round in shape, about 1.1 to 1.2 mm in
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diameter and have characteristic brown and white colored poles, a dark brown
animal pole and a yellowish vegetal pole (Figure). The oocytes were subsequently
maintained in MBS at 18 °C.

Figure 3.5: Isolated stage V and VI oocyte of Xenopus laevis after collagenase treatment.

3.3.3 Synthesis of cRNA
The cDNA clone of human α7-nACh was kindly provided by Dr. J.
Lindstorm (University of Pennsylvania, PA, U.S.A.). Capped cRNA transcripts were
synthesized in vitro using a mMESSAGE mMESSAGE kit (Ambion, Austin, TX,
U.S.A.) and analyzed on 1.2% formaldehyde agarose gel to check the size and
quality of the transcripts (Figure 3.6).
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Figure 3.6:Agarose gel analysis of mRNA.
Lane 1: NEB ssRNA ladder with 9,7,5,3,2,1, and 0.5 kilo bases markers.
Lane 2: 2 μg RNA of 5-HT3A receptor.
Lane 3 and 4: 1.5 and 0.75 μg mRNA of 5-HT3A receptor, respectively.
Lane 5: 3μg RNA of α7nACh receptor.
Lanes 6 and 7: 1.8 and 0.9 μg mRNA of α7 nACh receptor, respectively.

Human α7 nACh receptor mRNA was prepared by in vitro transcription and
confirmed by gel analysis. Restriction enzyme (Xbal) was used to digest the cDNA
of human α7 nACh receptor. Linearized plasmid cDNA was transcribed in vitro by
SP6 RNA polymerase to produce α7 nACh receptor RNA using a mMESSAGE
mMACHINE kit. This RNA was cleaned and purified by phenol:chloroform
extraction and ethanol precipitation. The quantity of RNA was estimated by OD260
measurement and quality was assessed by agarose gel. Capping enzyme and 2’-Omethyltransferase were used to add a cap and poly(A) tail to RNA, and the resulting
mRNA was suspended in DEPC-treated water. Once more, mRNA was cleaned by
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phenol:chloroform extraction and ethanol precipitation, then run against RNA in
agarose gel to confirm the addition of 5’ cap and 3’ poly(A) tail (Figure 3.7).
3.3.4 Injection of cRNA into oocytes
The concentration of human α7 nACh receptor mRNA synthesized was 3.7
µg/µL. It was stored in 1 µL aliquots in -80 °C freezers. On the day of injection only
one aliquot was transferred to the laboratory on ice. In order to control RNase
contamination, gloves and face mask were used and the bench was wiped with 70%
ethanol before handling cRNA. Eight µL of RNase and DNase-free water was added
to the cRNA using a sterile pipette and RNase free and DNase free tips (Denville
Scientific Inc., Metuchen, NJ, U.S.A.). Only 3 μl of diluted cRNA was used for one
batch of oocytes and the remaining cRNA was returned to the freezer.
A vertical puller was used to pull an autoclaved glass capillary (World
Precision Instruments, Sarasota, FL, USA) to make a needle with a long shaft. The
tip of the needle was broken by applying pressure using fine forceps (Fine Science
Tools Inc, Vancouver, BC, Canada) under the dissecting microscope (Bunton
Instrument Co, Rockville, MD, USA). The needle was back filled with mineral oil
(Sigma, St. Louis, MO, USA) using a glass 1 mL syringe. The needle was then
placed in the micro-dispenser connected to a micromanipulator. Before starting the
microinjection procedure, the surface of the microdispenser and the microscope was
cleaned with 70% ethanol. To the centre of a drop of mineral oil kept on parafilm
(American National Can, Greenwich, CT, USA), 3 µL of either diluted cRNA or
distilled water was transferred. Using the microscope, the intended aqueous phase
was carefully withdrawn into the needle using the microdispenser control panel.
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Thereafter, denuded selected oocytes are placed in a petri dish containing MBS and
having a mesh bottom to prevent movement of oocytes during the microinjection
procedure. Each oocyte was injected with 25 nL of mRNA by the nanoliter injector,
driven by a Micro-4, micro-syringe pump controller. Lastly, injected oocytes were
kept at 18 °C in a petri dish containing oocyte storage solution for 48 hours for
optimal expression of α7 nAChRs. The injected oocytes were used for
electrophysiological experiments during a period of one week. Every day after the
microinjection procedure, the storage solution was exchanged and dead or unhealthy
oocytes were removed.
3.3.5 Drug preparation
Stock solutions of tested compounds were prepared in millimolar
concentration in ND96 solution using the following formula:
Weight in mg = (MW) x (volume in L) x (mM concentration)
Further dilutions were prepared by using Charles equation:
C1 x V1 = C2 x V2
Where,
C1 = concentration of stock solution
V1 = volume of stock solution to be used
C2 = desired concentration to be prepared
V2 = desired volume to be prepared
Fresh stock solution and further dilutions were prepared before starting experiments.
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3.3.6 Two-electrode voltage clamp recording
Two-electrode voltage clamp (TEVC) is a conventional electrophysiological
technique used to artificially control (or clamp) membrane potential using feedback
amplifier in large cells to study the properties of electrogenic membrane proteins
such as ion channels. The functional properties of ion channels exogenously
expressed in Xenopus oocytes can be studied conveniently using this technique. In
TEVC, two intracellular microelectrodes are employed, a voltage sensor electrode
and a current injection electrode to control membrane voltage. In this way,
membrane potential can be set at a desired value and current through the membrane
can be recorded to analyze ion channel properties. The injected current to maintain
command voltage is equal to total membrane current (Figure 3.7).

Figure 3.7: Schematic illustration of two-electrode voltage clamp setup using Xenopus oocytes: The
membrane of the oocyte is penetrated by two microelectrodes, one for voltage sensing (V1) and one
for current injection (I2). The membrane potential as measured by V1 and a high input impedance
amplifier (amp1) is compared with a command voltage, and the difference is brought to zero by a high
gain feedback amplifier (amp 2). The injected current is monitored via a current-to voltage converter
to provide a measure of the total membrane current.
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The experimental setup for TEVC is depicted in Figure 3.2 and 3.7. At the
beginning of the experiments, perfusion containers and application systems were
filled with the appropriate solutions and allowed to run through the connected tubes.
The experiments were performed using the TEVC technique. For each experiment, a
single oocyte was placed in the recording chamber and continuously perfused with
ND96 solution at a rate of 3-5 ml/minute. The oocyte was impaled with two glass
microelectrodes (resistance ≈ 1-2 MΏ) prepared using a vertical microelectrode
puller (heater and solenoid values were adjusted to a setting of 50 and 70,
respectively; David Kopf Instruments Tujunga, CA, USA) and filled with 3 M KCl
solution. Drugs were applied by a gravity-based multichannel application system via
a micropipette positioned about 2-3 mm from the impaled oocyte. TEVC was
achieved using a Geneclamp 500 amplifier (Axon Instruments, Molecular Devices,
Inc., Sunnyvale, CA, USA), connected to a PC computer loaded with
electrophysiology software (Win WCP, University of Strathclyde, Glasgow, UK),
for data acquisition.
3.3.7 Parameters tested by electrophysiological recordings
3.3.7.1 Concentrations response curve (IC50 determination)
The oocytes were voltage-clamped at a holding potential of −70 mV using a
GeneClamp-500 amplifier (Axon Instruments, Molecular Devices, Inc., Sunnyvale,
CA, USA), and current response induced by application of 100 µM of acetylcholine
chloride (ACh) was recorded digitally on an IBM\PC.
A typical experiment began with three to five control recordings of α7 nACh
receptor ion currents induced by 100 µM of ACh with five minute intervals of
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washing with ND96 solution. The average of three to four stable readings was
calculated as the control value. Following the control recordings, the oocyte was
perfused for a total of 15 minutes with the selected concentration of tested
compound. The average of two to three responses at the end of the 15 min drug
application were calculated to determine the effect of the compound. Subsequently,
the application of drug was stopped and recovery recordings were taken for the 100
µM ACh again with 5 minutes intervals of ND96 perfusion.
The percent inhibition was calculated by dividing the average of currents
induced in presence of the selected concentration of the tested compound by the
average control values obtained before drug application. These values were
normalized and displayed as percent of changes in current size (compared to
controls). Monoterpenes such as carveol and carvacrol were used at varying
concentrations to construct dose-response curves. The concentration of a compound
which produced 50 % inhibition of ACh-induced currents (IC50) was determined by
nonlinear curve-fitting and regression fits (logistic equation) using computer
software (Origin, OriginLab Corp., Northampton, MA, U.S.A.). Different
concentrations of compounds were plotted on the X-axis and % inhibition of ion
current of respective concentrations was plotted on the Y-axis. Concentrations of
drugs close to their IC50 values were employed for further studies. Also, 10 µM
effect of monoterpenes such as L-carvone, eugenol, vanillin and (+)-pulegone was
examined for comparison. With the exception of vanillin, all compounds were water
insoluble. These compounds were first dissolved in 100% dimethyl sulfoxide
(DMSO). DMSO, at the final concentration of 0.001 % (v/v) used in our studies, did
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not induce a statistically significant effect on the maximal amplitudes of AChinduced currents.
3.3.7.2 Experiments on the competitive and non-competitive nature of
monoterpene inhibition
Concentration-response curves for ACh were determined by using increasing
ACh concentrations starting from 3 μM to 3 mM. The effects of carveol on different
concentrations of ACh-induced currents were determined in the absence and
presence of this compound. During these experiments, oocytes were voltageclamped at a holding potential of −70 mV and three gradually increasing
concentrations of ACh and maximal ACh (3 mM) were used on a single oocyte. For
any set of concentrations of ACh, experiments were repeated in 5-6 different oocytes
and percent inhibition was calculated as described earlier.
3.3.7.3 Experiments on the voltage-dependency of drug inhibition
Voltage-dependence of the compound's action was determined by holding the
membrane potential at different values for 30 s. At each point, membrane potential
was returned to -70 mV, and subsequent readings were taken every five minutes.
During these experiments, ACh was used at a concentration of 100 μM. Currentvoltage (I-V) relationships for ACh-induced currents were determined in the absence
and presence of tested compound.

63

3.3.7.4 Experiments on the determination of Ca+2 contribution to observed drug
action
In

this

series

of

experiments,

50

nL

of

BAPTA

(1,2-bis(o-

aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) stock solution (100 mM) was
injected into each oocyte (Sands, Costa & Patrick, 1993). Stock solution of BAPTA
was prepared in distilled-water and the pH was adjusted to 7.4 by CsOH. Following
BAPTA-injections, oocytes were kept in ND96 for 5 to 10 min, and placed in a
ND96 solution containing Ba2+ instead of Ca2+(prepared ND96 solution contained
1.8 mM BaCl2 instead of 1.8 mM CaCl2). In order to determine the contribution of
intracellular Ca2+ levels, the effect of the tested compound on the ACh-induced
currents in BAPTA injected oocytes were investigated in either Ca2+ or Ba2+
containing ND96 solutions, and the extent of drug inhibition was compared.
3.3.7.5. Experiments for determination of the effect of exposure time on the
compound's action
In this set of experiments, the compound's perfusion time was changed
starting from zero exposure time (Ach is coapplied with the tested compound
without prior incubation of that compound) to a maximum of 15 minutes of
preincubation with the compound. Effect of increasing exposure time was analyzed
by comparing the change in percent inhibition of the fixed concentration of the
compound tested. These experiments were repeated on 5-6 different oocytes.
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3.3.8. Data analysis
For the nonlinear curve-fitting, the computer software Origin (Origin Lab
Corp., Northampton, MA, U.S.A.) was used. Average values were calculated as the
mean ± standard error of the mean (SEM). Statistical significance was analyzed
using Student's t-test or ANOVA as indicated. Concentration-response curves were
obtained by fitting the data to the logistic equation,
y = Emax / (1+[x/EC50]-n),
Where x and y are drug concentration and response, respectively, Emax is the
maximal response, EC50 is the half-maximal concentration, and ‘n’ is the slope factor
(apparent Hill coefficient).
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Chapter 4: Results
4.1 Functional expression of the human α7-nACh receptor in Xenopus oocytes
Application of 100 µM of acetylcholine (ACh) did not cause noticeable
currents in uninjected oocytes (n=11) or in oocytes injected with distilled water
(n=38). When oocytes injected with cRNA transcribed from cDNA encoding the α7
human nACh receptor were used, application of 100 µM ACh for 3 to 4 seconds
caused fast inward currents that were rapidly desensitized (Figure 4.1 A, left panel).
Co-application of 30 nM α-bungarotoxin, a potent nAChR antagonist obtained from
snake venom, with 100 µM ACh caused almost complete inhibition of ACh-induced
currents (n=14), indicating that the response was mediated by α-bungarotoxinsensitive neuronal α7 nAChRs (4.1A, middle panel). After a 30-40 minutes washing
period, incomplete or no recovery of the neurotoxin effect was observed (Figure
4.1A, right panel). Data from these experiments is presented in Figure 4.1B.
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Figure 4.1: Functional expression of human α7 nACh receptors in Xenopus oocytes.
A. Records of currents induced by ACh (100 μM) in control conditions (left) during co-application of
30 nM -bungarotoxin and ACh after 10 min preincubation with 30 nM -bungarotoxin (middle),
and 15 min following α-bungarotoxin washout (right). B. Bar presentation of the means of the
maximal amplitudes of ACh-induced currents in distilled water injected oocytes and human α7 nACh
receptor cRNA injected oocytes are shown on the left-side of the Figure 1B. In oocytes injected with
human α7 nACh receptor cRNA, the mean maximal amplitudes of ACh-induced currents in the
presence and absence of α-bungarotoxin (30 nM) were presented on the right-side of the Figure 1B.
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4.2 The effect of selected monoterpenoids on the function of human α7 nACh
receptor
Initial experiments were done to screen the effects of various selected
monoterpenes at 10 µM concentration, on the function of α7 nACh receptors.
Eugenol, d-carvone and vanillin did not have a significant effect on α7 nACh
function. Carvacrol, carveol, thymol and pulegone caused variable inhibitory effects
of ACh (100 µM)-evoked currents. Carvacrol, thymol and carveol caused significant
effects while pulegone caused weak inhibition (~20%). Carveol showed maximum
inhibition (57%) of 100 µM ACh-induced current through α7 nAChR-expressing
oocytes and therefore it was selected for further investigations. Summary of the
effects of 15 minutes bath applications of monoterpenes on the ACh-induced ion
currents are shown in Figure 4.2.
Traces of currents showing the inhibitory effect of carveol are presented in
Figure 4.3. In these experiments, in the absence of the tested monoterpene, maximal
amplitudes of currents elicited by the application of 100 µM ACh every 5 min
remained unchanged in experiments lasting 50-60 min (control record in left panel of
Figure 4.3 and open circles in Figure 4.4). However, bath application of 10 µM
carveol caused a gradually developing strong inhibition of α7 nACh receptors
(Figure 4.3, middle panel). Time-course of the effect of 10 µM carveol application
for 15 min on the amplitudes of ACh-induced currents is presented in Figure 4.4.
The inhibition by carveol was almost reversible within 10 to 15 min of washout
period (Figure 4.3, right panel). In the presence of caveol, there was a statistically
significant difference in the amplitudes ACh-induced currents (n=7, ANOVA, P <
0.05).
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It was noteworthy that the inhibitory effect of carveol was dependent on the
application or exposure period. As depicted in Figure 4.5, without preincubation, the
coapplication of carveol (10 μM) and ACh (100 μM) caused minimal inhibition (0
time point in the Figure 4.5). However, incubation with carveol caused a significant
inhibition which reached a maximal level with a half-time (τ1/2) of 3.4 min (n=4;
Figure 4.5). As the magnitude of carveol effect was time-dependent, 10 to 15 min
carveol application was routinely used in the rest of the experiments to ensure that
equilibrium conditions for the monoterpene action were achieved.
Carveol's inhibitory effect of α7 nAChRs was concentration-dependent with
IC50 of 8.3± 0.9 µM (Figure 4.6). Based on these findings, 10 μM of carveol was
employed routinely in the rest of the experiments.
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Figure 4.2: Effects of selected monoterpenes on α7 nACh receptor-mediated ion currents.
Bar-graph displaying the means of % of effect of 10µM of tested monoterpene on 100µM Ach
elicited α7 nACh currents. Data represents the mean ± S.E.M of indicated number of oocytes.

Figure 4.3: Current traces of carveol’s effect on α7 nAChR currents.
Records of currents activated by ACh (100 μM) in control conditions (left) during co-application of
10 μM carveol and ACh after 10 min pre-treatment with 10 μM carveol (middle), and 15 min
following carveol washout (right).
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Figure 4.4: Time-course of carveol inhibition of α7 nACh receptor-mediated ion currents.
Inhibition of α7-nACh receptor is reversible after wash out of carveol. Data points represent the mean
± S.E.M of 4 to 6 oocytes.
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Figure 4.5: Time-dependence of carveol inhibition of α7 nACh receptor-mediated ion currents.
Inhibition of α7 nACh receptor increases with the prolongation of carveol application time. The half
maximal inhibition was reached within a half-time (τ1/2) of 3.4 min. Data points represent the mean ±
S.E.M of 6 oocytes.
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Figure 4.6: Concentration-dependent inhibitory effects of carveol on α7 nACh receptor currents.
Carveol inhibits the function of α7 nACh receptor in a concentration-dependent manner. Data points
represent the mean ± S.E.M of 6 to 8 oocytes. The curve is the best fit of the data to the logistic
equation described in the methods. The IC50 is 8.3 ± 0.9 µM.

4.3 The role of intracellular calcium levels in carveol-inhibition of α7 nACh
receptor
Some monoterpenoids were reported to alter intracellular Ca2+ homeostasis in
different cell types (Chang et al, 2011; de Cerqueira et al, 2011). In the oocyte
expression system, the increased level of intracellular Ca2+ can be detected by
Ca2+activated Cl- channels and concomitant alterations in the holding currents. In
control experiments, carveol alone (10 µM for 15 min) did not alter the magnitude of
holding current in oocytes voltage-clamped at –70 mV (n=12), indicating that
intracellular Ca2+ levels were not altered by carveol.
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As previously mentioned, high Ca2+ permeability is an important
physiological characteristic of α7 nAChR (Albuquerque, 2009; Vernino et al, 1992).
Ca2+-activated Cl- channels have been shown to be expressed endogenously in
Xenopus oocytes (Miledi, 1982). Activation of α7 nAChRs allows influx of
sufficient amounts of Ca2+ to activate endogenously expressed Ca2+-dependent Clchannels in Xenopus oocytes (Sands et al, 1993; Seguela et al, 1993). Therefore, it
was necessary to investigate whether the effect of carveol was mediated by its direct
actions on α7-nAChRs or by the subsequent activation of Cl- currents induced by
Ca2+ entry through nACh receptors. In this set of experiments, extracellular Ca2+ was
replaced with Ba2+ since Ba2+ can pass through α7-nAChRs but causes little, if any,
activation of Ca2+-dependent Cl- channels (Barish, 1983; Sands et al, 1993).
In the presence of Ba2+, some activity of Ca2+-dependent Cl- channels has
been reported. The contribution of the remaining Ca2+-dependent Cl- channel activity
has been shown to be abolished by injection of the Ca2+ chelator BAPTA (Sands et
al, 1993). For this reason, we recorded ACh-induced currents in presence and
absence of 10µM carveol using BAPTA-injected oocytes bathed in a Ba2+ containing
solution. Carveol produced the same level of inhibition (54 ± 6 % in controls versus
48 ± 7 % in BAPTA-injected oocytes n=5-8; ANOVA, P > 0.05) of ACh-induced
currents when BAPTA-injected oocytes were recorded in Ca2+ free, 2 mM Ba2+
containing solutions (Figure 4.7).
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Control

Figure 4.7: Carveol inhibition of ACh-induced currents is independent of Ca2+-activated Clchannels. α7 nACh expressing oocytes injected with 50 nl distilled water and recorded in 2 mM
Ca2+ containing MBS solution or injected with 50 nl of BAPTA (100 mM) and recorded in 2 mM
Ba2+ containing MBS solution. Data represent the means ± S.E.M of 10 experiments. There was no
statistically significant difference in the carveol (10 μM) inhibition in the presence or absence of
BAPTA injection (P>0.05, n=5-8, ANOVA).

4.4 The voltage-dependence of carveol action on the α7 nACh receptor
Voltage-dependence of carveol-inhibition was examined on α7 nACh
receptors. Each tested membrane potential was held for 30 s and then returned to -70
mV. As shown in Figure 4.8A, the inhibition of 100 µM ACh-induced currents by
carveol (10 µM) does not appear to be voltage-dependent. At all tested membrane
potentials from -100 to -20 mV, the extent of carveol inhibition were similar.
Evaluation of data from current-voltage relationship displayed that there is no
significant difference in the extent of the inhibitory effect of carveol of α7 nAChR
currents at different holding potentials (Figure 4.8B; P>0.05, n=6, ANOVA).
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Figure 4.8: Carveol inhibition of ACh-induced currents is independent of membrane potential.
A. Current-voltage relationships of ACh-activated currents in the absence and presence of carveol (10 μM).
Normalized currents activated by 100 μM ACh before (Control,) and after 10 μM carveol treatment. B.
Quantitative evaluation of the effects of carveol is presented as percent inhibition at different voltages
indicated in panel B. Data points represent the mean ± SEM of 7 to 8 experiments.

76

4.5 Studies on the competitive or non-competitive nature of carveol's inhibitory
effect of α7 nACh receptor
Carveol may decrease the binding of the agonist to the receptor by acting as
either a competitive or non-competitive antagonist. For this reason, the effect of
carveol was examined at different concentrations of ACh. Concentration-response
curves for ACh in the absence and presence of 10 µM carveol are presented in
Figure 4.9. Carveol caused a right-ward shift of the concentration-response curve,
without causing a decrease on the the maximal ACh-induced current. In the absence
and presence of carveol, the EC50 values were 94 ± 8 μM and 248 ± 14 μM (n=7),
and slope values were 1.6 ± 0.2 and 1.7 ± 0.3 (n=7), respectively, suggesting that
carveol inhibits the ACh responses in a competitive manner.
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Figure 4.9: Concentration-response curves for acetylcholine-induced currents in the presence and
absence of 10µM carveol.
Oocytes were voltage-clamped at -70 mV and currents were activated by applying acetylcholine (100
μM). Oocytes were exposed to 10 µM carveol for 15 min and ACh was reapplied. Paired
concentration-response curves were constructed and responses normalized to maximal response under
control conditions. EC50 and slope values were determined by fitting the curves from 5 oocytes to the
standard logistic equation as described in the methods section. Data points obtained before (Control)
and after 15 min treatment with carveol (10 μM) were indicated by filled and open circles. Data points
represent the normalized mean ± SEM of 6 to 8 experiments.
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Chapter 5: Discussion
In this study, we provide electrophysiological evidence indicating that some
monoterpenes inhibit the function of human α7 nACh receptor expressed in Xenopus
oocytes. There were significant differences in the effects and the extent of activity
among the monoterpenes tested in this study. At the same selected concentration, 10
µM, vanillin showed weak activation (<10% of control readings), d-carvone almost
had no effect while all other monotepenes demonstrated variable extent of inhibition.
In the order of potency of inhibitory effect of the amplitude ACh-induced currents,
carveol was most potent, then thymol, carvacrol, pulegone and least is eugenol (see
Figure 4.2). Further experiments focused on carveol, being most potent among all
tested monoterpenes. Our results demonstrated that preincubation time was a
significant factor determining the extent of carveol inhibition. The time course
required for carveol to show its effect on α7 nACh receptors was relatively slow (τ =
3.4 min). This might indicate possible interaction of carveol with the lipid
membrane. As stated earlier, monoterpenes are lipophilic in nature and several in
vitro studies on either artificial membrane systems, selected bacterial cells or
mammalian cell lines demonstrated alteration of cell membrane properties to
variable extents (Cristani et al, 2007; de Carvalho & da Fonseca, 2007; Di Pasqua et
al, 2006; Reiner et al, 2013a; Reiner et al, 2009).
Ion channel blockers can have different mechanisms of actions. Depending
on the type of ion channel and the blocker, the channel may be stabilized in the
closed state leading to decreased rate and/or duration of the opened state. Many
blockers inhibit channel activity by physically obstructing the channel pore near the
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selectivity filter. This is known as open-channel blockade (Hille, 2001).
Open-channel blockade is widely accepted as a model to describe the block
of ligand-gated ion channels (Hille, 2001; Hille & Dennis, 2010). However, this
model cannot account for the results of the present study. Firstly, for an open
channel blocker to act, the co-existence of the agonist and blocker is required to
allow the blocker to enter the channel pore as a result of agonist-induced
conformational change and channel opening. However, there was no inhibition of
nACh receptors during coapplicaiton of ACh and carveol. Increased preincubation
period enhanced carveol-induced inhibition of channel activity (Figure 4.4),
indicating that carveol can interact with the closed state of the α7 nACh receptor.
Secondly, inhibition by carveol is not voltage sensitive (Figure 4.8), suggesting that
the carveol-binding site is not influenced by the transmembrane electric field.
In electrophysiological studies, the EC50 value of ACh, a natural ligand
(agonist) for this receptor, increased significantly from 94 µM in controls to 248 µM
in the presence of carveol. Efficacy of ACh remained unaltered in the presence of
carveol. However, the potency was decreased significantly, indicating that carveol
competes with the ACh binding site on the receptor.
Earlier studies in mammalian cells showed that monoterpenes such as thymol
(Szentandrassy et al, 2004; Szentesi et al, 2004) and eugenol (Lofrano-Alves et al,
2005) causes alteration of intracellular Ca2+ handling and Ca2+ mediated signal
transduction pathways . As α7 nACh receptors are known to have high Ca2+
permeability, activation of those receptors in Xenopus oocytes can permit sufficient
Ca2+ entry to possibly activate endogenous Ca2+ dependent Cl- channels (Sands et al,
1993; Seguela et al, 1993). Carveol was still able to inhibit α7 nACh receptor-
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mediated ion currents in oocytes injected with BAPTA and superfused with Ba2+
containing solution, suggesting that Ca2+ dependent Cl- channels were not involved
in carveol-induced inhibition of nicotinic responses (Figure 4.7). In addition, as the
Ca2+ activated Cl- channels are highly sensitive to intracellular levels of Ca2+ (for a
review see Fraser & Djamgoz, 1992; Machaca et al, 2002; Weber, 1999), the
alterations in intracellular Ca2+ levels would be reflected by changes in the holding
current under voltage-clamp conditions. However, during our experiments,
application of carveol, even at the highest concentrations (300 μM in n = 6), did not
influence the baseline or holding currents, suggesting that carveol did not affect
intracellular Ca2+ levels.
It appears therefore that the actions of carveol reported in our study, are not
mediated by changes in intracellular Ca2+ levels, and independent of the enterence of
extracellular Ca2+ through α7 nACh receptors.
5.1 Monoterpenes concentrations used in this study
Monoterpenes, in the concentration range used in the study have been shown
to modulate the functions of several other receptors and ion channels. For example,
menthol causes concentration-dependent inhibition of the α7 nACh receptors
expressed in Xenopus oocytes with an IC50 of 32.6 µM (Ashoor et al, 2013a). An
earlier study showed that camphor inhibited nACh receptor function with an IC50 of
70 µM in bovine adrenal chromaffin cells (Park et al, 2001). Similarly, borneol also
showed an inhibitory effect on nACh receptors functions with a smaller IC50 of 56
µM (Park et al, 2003). Also screening the effects of monoterpenes, thymol and
carvacrol, on the functions of 5-HT type 3 receptors expressed in Xenopus oocytes,
10 µM concentration, when coapplied with small concentration of 5-HT (EC25),
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caused significant potentiation of the response (Lansdell et al, 2015). Moreover,
previous reports showed that coapplication of 50 µM menthol with GABA caused 2
fold potentiation of the response to GABAA receptors which are also expressed in
Xenopus oocytes (Hall et al, 2004). Thymol showed similar effects on GABAA
receptors concentration-dependently over the range 1-100 µM (Priestley et al, 2003).
These results suggest that the concentrations of monoterpenes (Carveol IC50= 8.3
µM) are in a similar range to earlier reports.
5.2 Functional importance of monoterpenes actions on human α7 nACh
receptor
It has been shown that a number of monoterpenes improve the cognitive
performance in patients with cognitive disorders such as Alzheimer disease (Dalai et
al, 2014; Khan et al, 2014; Perry et al, 2003; Perry et al, 2001; Videira et al, 2014) .
Most of these studies demonstrated the value of tested monoterpenes in Alzheimer
disease and improvement of cognitive impairment through either anticholinestrase
activity or inhibition of β-amyloid accumulation which is one of the key steps in the
progression of the disease. Modulation of specific nicotinic receptors is another
possible mechanism that might be of value. Since neuronal 42 and α7 nACh
receptors have been strongly associated with cognitive function (Haydar & Dunlop,
2010; Levin, 2002; Okada et al, 2013; Picciotto et al, 2000) further investigations for
the interaction of monoterpenes with these nACh receptor subtypes may be useful
for drug development. It was evident from several earlier studies that agonistic
effects on nicotinic receptors are associated with beneficial effects of various drugs.
Interestingly, the monoterpenes tested in our study showed antagonistic actions on
α7 nACh receptors.
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Agonistic actions of drugs on nicotinic receptors can be mediated by
activation of nACh receptors or indirectly by increasing the release of
neurotransmitter (for review, see Dorostkar & Boehm, 2008). However, it has been
shown in several earlier studies that both nicotine and nACh receptor antagonists
have almost similar effects (Anderson & Brunzell, 2012; Picciotto et al, 2008). For
example, high doses of nAChR antagonists such as -bungarotoxin, d-tubocurarine
and mecamylamine have been shown to cause excitatory responses (promoted
population spikes) in rat CA1 hippocampal slices that were similar to those produced
by nicotine (Ropert & Krnjevic, 1982). Another study using mouse hippocampal
slices demonstrated an increase in amplitude of population spikes caused by bathapplication of nicotine and the antagonists such as d-tubocurarine and αbungarotoxin acted in a very similar manner (Freund et al, 1990). In another in vitro
study, both nicotine and methyllycaconitine (selective 7 nACh receptor antagonist)
reversed the muscimol induced block of long-term potentiation (LTP) after their
application to CA1 region of the hippocampus (Fujii et al, 2000a; Fujii et al, 2000b).
Furthermore, application of nicotine as well as high concentration of the
nicotinic antagonist mecamylamine increased serotonin release in rat dorsal
hippocampal slices despite smaller concentration of the antagonist blocked nicotineinduced effects when both were co-applied (Kenny et al, 2000; Mihailescu et al,
1998).

Another study has shown that mecamylamine and the high-affinity

antagonist, dihydro--erythroidin, exerted effects similar to nicotine on dopamine
release under conditions of phasic and tonic activity (Rice & Cragg, 2004).
It was reported that mecamylamine, in low doses, promotes the performance

83

in memory-related tasks to an extent comparable to nicotine. For instance, chronic
administration of 3 mg/kg doses of mecamylamine was found to reverse the nicotineinduced improvement in spatial working memory in the radial-arm-maze test (Levin
et al, 1993). Nevertheless, when mecamylamine was given alone to tested rats, it
caused unexpected significant improvement in radial-arm-maze working memory
performance during the first week of infusion (Levin et al, 1993). Using also radialarm maze with repeated acquisition procedure, low dose range of mecamylamine
showed significant improvement in learning relative to saline (Levin & Caldwell,
2006). It was also shown that chronic administration of mecamylamine had complex
effects using T-maze alternation test. During the early phase of administration, there
was a paradoxical improvement in working memory performance, but during the
latter period of administration there was a deficit (Levin et al, 1997). Moran saw a
similar paradoxical improvement in T-maze alternation with mecamylamine when
given as an acute injection of 10 mg/kg (Moran, 1993). Corroborating evidence
regarding the dose-specific effects of mecamylamine on memory was also gained
using non-human primates as administration of mecamylamine caused improved
performance of delayed matching-to-sample accuracy in monkeys (Terry et al,
1999). Similar improvements in cognition were also evident following low doses of
methyllycaconitine, a selective α7 nAChR antagonist, in a rodent model of attention
(Hahn et al, 2011). In the absence of nicotine, low doses of methyllycaconitine (0.4
and 1.3 mg/kg) improved response accuracy although concurrent administration with
nicotine caused reversal of nicotine-induced attention-enhancing effects. In the same
study, dihydro-β-erythroidine, a competitive antagonist at α4β2, α4β4, α3β2 and
α2β2 nAChRs, almost showed almost no effect compared to control, indicating that
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the α7 nAChR subtype may have a fundamental role in cognitive function (Hahn et
al, 2011). The role of nACh receptor desensitization in mediating the effects of
nicotine and nicotinic antagonist has been reviewed recently (Buccafusco et al, 2009;
Picciotto et al, 2008). It has been concluded that an overall decrease in nicotinic
stimulation could be clinically valuable for cognitive enhancement. In a recent study,
group of researchers (Dobryakova et al, 2015) studied the effects of different
nicotinic receptor antagonists on passive avoidance learning in rodents and
demonstrated that mecamylamine, when given after a training phase, had positive
effects on memory consolidation. In a pilot study (Potter et al, 2009) where human
participants i.e. fifteen non-smoking young adults diagnosed with attention deficit
hyperactivity disorder (ADHD), received, in a double-blind fashion, an acute, single
dose of mecamylamine (0.2, 0.5 or 1 mg) orally and placebo. Mecamylamine
showed beneficial effects on recognition memory with the 0.5 mg dose. Similar
finding on recognition memory was demonstrated when acute nicotine dose was
given for young adolescents with ADHD (Potter & Newhouse, 2004; Potter &
Newhouse, 2008).
The similarities in effects of nicotine and nAChR antagonists were also seen
at cellular level and on receptor regulation. Continuous treatment with
mecamylamine in vivo or in vitro experiments was reported to cause brain region
specific and/or subtype-specific upregulation of nACh receptors in a way similar to
the effect of nicotine (Abdulla et al, 1996; Collins et al, 1994; Pauly et al, 1996;
Peng et al, 1994). Some studies have demonstrated modulation of downstream
signaling events as a result of nACh receptor antagonism. In vitro exposure of PC12
cells to nicotine (0.01-10 µM) for 24 hours produced an increase in the level of
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expression of tropomyosin receptor kinase A (TrkA) receptors, high affinity nerve
growth factor receptors, that was reversed upon concurrent exposure to
mecamylamine (5 μM) (Jonnala et al, 2002). Interestingly, exposure to low
concentration of mecamylamine (10-100 nM) in the absence of nicotine also induced
a significant increase in expression of TekA receptors with reference to control.
Consistent with the in vitro findings, in vivo administration of mecamylamine (24
mg/kg/day) caused a moderate increase (20%) in expression of TrkA receptors
(Jonnala et al, 2002). This suggests a possible neuroprotective effect of nACh
receptor antagonist that is important for delaying or preventing neural degeneration
associated with cognitive deficits. Collectively, these effects may contribute to the
procognitive effects of nACh receptor antagonism.
As described earlier, α7 nACh receptors are characterized by fast
desensitization, and this makes it difficult to discriminate whether the effects of α7
nACh receptor agonists are due to direct activation or subsequent activation-induced
receptor desensitization (Banerjee et al, 2005). Binding of agonists stabilizes the
desensitized state of the receptor. This state display high affinity for ACh and other
ligands binding, nevertheless, receptor becomes unresponsive to subsequent
stimulus. As a result, chronic exposure to nicotine was demonstrated in animal
studies and in smoking human subjects to induce strong compensatory receptor
upregulation (Benwell et al, 1988; Parker et al, 2014; Perry et al, 1999). In this
context, it has been suggested that many of the nicotinic effects can be explained as a
result of receptor desensitization rather than activation (Picciotto et al, 2008). It is
still unclear whether agonists of nACh receptors are truly functioning in vivo as
antagonists due to desensitization process.
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Chapter 6: Conclusion

Monoterpenes display variable biological activities like analgesic, antiinflammatory and anticancer effects. This is, to our knowledge, the first study
reporting effects of several monoterpenes on the function of the human α7nACh receptor, a ligand-gated ion channel. The results obtained in this study
suggest an inhibitory effect of monoterpenes on the function of α7 nACh
receptors. It appears that the extent of inhibitory action varies significantly
among the different monoterpenes.

6.1 Limitations and future directions
In our study, we did not examine monoterpenes effects on mammalian
cell lines and native neurons. It is possible that post-translational modification
and interacting proteins in Xenopus oocytes are different from mammalian cells.
In future studies, we intend to study the effect of monoterpenes on the other
nicotinic ACh receptor subtypes to determine the specificity of monoterpenes
action on these receptors. We are also interested in conducting experiments to
further study the structure activity relationship of these phytochemicals on
nicotinic receptors expressed in mammalian cell lines.
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